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Aim: To study resuscitation and post-resuscitation care strategies, including outcomes, 
and factors contributing to outcome, in and outside the hospital in Finland with reference to 
the Utstein Guidelines, for uniform data collection from 1997 and to the current international 
Resuscitation Guidelines from 2000.  
Materials and methods: In-hospital resuscitation strategies in Finland were assessed 
using a cross-sectional mail survey, and by prospectively collecting cardiac arrest (CA) 
management data as recommended and defined by the Utstein Guidelines, in four secondary 
hospitals during one year (Studies I-III). The management of patients with out-of-hospital 
CA (OHCA), emphasizing use of undiluted amiodarone and subsequent hospital care, was 
evaluated retrospectively by analysis of data from the ambulance´ and hospital charts 
(Studies IV-V).   
Results:  A majority of Finnish hospitals had an appointed physician or nurse in charge 
of in-hospital cardiopulmonary resuscitation (CPR) activities. Despite this most hospitals 
stated that the in-hospital training activities were insufficient. Few hospitals had strategies 
for early defibrillation outside the cardiac care units (CCU) and intensive care units (ICU). 
The short-term outcome rates of in-hospital CPR in four Finnish secondary hospitals were 
similar, and the long term outcome rates were lower, than rates previously reported. The 
only factor shown to be associated with survival was the delay to defibrillation in patients 
with an initial rhythm of either ventricular fibrillation (VF) or ventricular tachycardia (VT). 
Most patients who had a CA, from whom CPR was withheld, had, prior to the arrest, a 
valid “do not resuscitate” (DNR) order in place - nowadays often called “do not attempt to 
resuscitate” (DNAR) - but it was not uniformly documented in the patient charts. Variations 
in the prevalence of DNAR orders among those patients that were not resuscitated were 
evident between and within hospitals. 
 Blood pressure levels after return of spontaneous circulation (ROSC) were similar among 
patients who did or did not receive amiodarone as an undiluted bolus; patients with asystole 
or pulseless electrical activity as the initial rhythm did not survive to hospital discharge. For 
patients admitted alive after OHCA, age, delay before ROSC, mean 72-hour blood glucose 
and plasma (or serum) potassium levels, and use of beta-blocking agents during post-
resuscitation care independently predicted survival at six months after the event.  
Conclusions: Given the recommendations of the current Resuscitation Guidelines, 
this study suggests that in-hospital CA management strategies in Finland would need 
improvement. This situation is probably not unique to Finland. The Utstein Guidelines were 
found to be a useful but laborious tool collection of data on in-hospital CAs. The low rate of 
long-term survival (9%) after CA may in part be due to factors not open to organizational 
intervention. In any case and based on the results, it seems logical to shorten the delay to 
defibrillation in patients with VF/VT as the initial rhythm, especially in CA occurring outside 
the CCU and the ICU. The application of DNARs was common, but lack of recommendations 
on uniformity probably contributed to the inconsistencies in charting. 
 Amiodarone can be administered undiluted for treatment of arrhythmias in resuscitation, 
which simplifies the OHCA treatment protocol. Based on the present records, its impact, 
if any, on the outcome of patients with OHCA, with initial rhythms other than VF/VT, 
remains open. Several in-hospital factors (e.g., blood glucose, blood potassium and use 
of beta-blocking agents during post-resuscitation care) independently predicted survival 
after OHCA. Bringing some of these factors closer to standard values might benefit these 
patients.
This thesis is based on the following original publications, which will be referred to in the 
text by their Roman numerals I to V.
I Skrifvars MB, Castrén M, Kurola J, Rosenberg PH. In-hospital cardiopulmonary 
resuscitation management: organization, management and training in hospitals of different 
levels of care. Acta Anaesthesiol Scand 2002;46:458-63
II Skrifvars MB, Rosenberg PH, Finne P, Halonen S, Hautamäki R, Kuosa R, Niemelä H, 
Castrén M. Evaluation of the in-hospital Utstein template in cardiopulmonary resuscitation 
in secondary hospitals. Resuscitation 2003;56:275-82.
III Skrifvars MB, Hilden HM, Finne P, Rosenberg PH, Castren M. Prevalence of “do not 
attempt resuscitation” orders and living wills among patients suffering CA in four secondary 
hospitals. Resuscitation 2003;58:65-71.
IV Skrifvars MB, Kuisma M, Boyd J, Repo J, Määttä T, Rosenberg PH, Castrén M. The 
use of undiluted amiodarone in the management of OHCA. Acta Anaesthesiol Scand 2004 
(in press).
V Skrifvars MB, Pettilä V, Rosenberg PH, Castren M. A multiple logistic regression 
analysis of in-hospital factors related to survival at six months in patients resuscitated from 
out-of-hospital ventricular fibrillation. Resuscitation 2003;59:319-28.
The articles are reprinted with the kind permission of the copyright holders.
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AED Automated external defibrillator
ACLS Advanced cardiac life support
AHA American Heart Association
ALS Advanced life support
BLS Basic life support
CA Cardiac arrest
CABG Coronary artery bypass grafting 
CCU Cardiac care unit
CPC Cerebral performance category
CPP Coronary perfusion pressure
CPR Cardiopulmonary resuscitation
DAP Diastolic arterial blood pressure
DNAR Do not attempt to resuscitate
DNR Do not resuscitate
EK-CH Etelä-Karjala Central Hospital
EMS Emergency medical service
ER Emergency room
ERC European Resuscitation Council
GW General ward
HIE Hypoxic-ischaemic-
 encephalopathy
ICU Intensive care unit
IHCA In-hospital cardiac arrest
ILCOR International Liaison Committee 
 on Resuscitation
IQR Interquartile range
J-CH Jyväskylä Central Hospital
MAP Mean arterial blood pressure
MET Medical emergeny team
MI Myocardial infarction
The treatment of cardiac arrest (CA) 
with cardiopulmonary resuscitation (CPR), 
including mouth-to-mouth ventilation and 
external chest compression, today widely 
known as basic life support (BLS), was 
described in the 1950s [3-5]. In the 1960s, 
the treatment concept was enhanced 
by external electric defibrillation [6-8], 
and the use of various drugs [9,10]: the 
entity called advanced life support (ALS) 
evolved. Extensive epidemiological and 
clinical research has identified several 
factors associated with increased as well 
as decreased survival from CA. The “chain 
of survival” [11], outlined during the early 
1990s, summarizes the most important 
factors.
 At first, CPR was practiced only in 
hospitals. However, through a great amount 
of work, with the organization of pre-
hospital emergency medical services (EMS), 
the outcomes and survival rates of patients 
with CA outside the hospital, have improved. 
It is doubtful whether a similar degree of 
improvement has occurred in the outcome 
of patients experiencing in-hospital cardiac 
arrest (IHCA). Survival rates for in-hospital 
CPR have remained fairly constant, in the 
range of 10 to 15%, but at the same time, the 
total number of CPR attempts has increased 
[12], meaning probably on sicker patients. 
The variety of in-hospital resuscitation 
strategies does not, however, seem to have 
changed much since the early 1970s.       
 Resuscitation research, both in and outside 
the hospital, has been rendered difficult by 
inconsistencies both in data collection and 
– ABBREVIATIONS AND DEFINITIONS –
NS Not statistically significant
OHCA Out-of-hospital cardiac arrest
OPC  Overall performance category
OA Operating area
PCI Percutaneous coronary 
 intervention
PEA Pulseless electrical activity
PH-CH Päijät-Häme Central Hospital
PSDA Patient Self-Determination Act
ROSC Return of spontaneous 
 circulation
SAP Systolic arterial blood pressure
V-CH Vaasa Central Hospital
VF Ventricular fibrillation
VT  Ventricular tachycardia
The Utstein Guidelines for reporting 
outcomes of in-hospital cardiac arrests:
Reporting guidelines published as a result 
of a consensus conference held at the Utstein 
Abbey, Stavanger, Norway, in the year 1996 
and published in the year 1997 [1]
Guidelines 2000 for Cardiopulmonary 
Resuscitation and Emergency Cardiovascular 
Care: The first international resuscitation 
guidelines published jointly by the AHA and 
the ERC in the year 2000 [2]
– INTRODUCTION –
in reporting. Acknowledging this important 
problem, a consensus conference produced 
the Utstein style guidelines for out-of-
hospital cardiac arrest (OHCA) in 1991 
[13] and for IHCA in 1997 [1]. Thus far, the 
Utstein Guidelines have been very useful, 
although with certain limitations [14,15].
 IHCA and resuscitation can be considered 
a complex medical problem which also 
involves medico-ethical issues. Research 
on in-hospital resuscitation is complicated 
by several confounding variables, and its 
true efficacy is yet to be determined. In 
addition, several other aspects of in-hospital 
cardiopulmonary resuscitation and of CA 
in general require supplementary research, 
such as the impact of in-hospital care after 
OHCA and the use of “do not resuscitate” 
(DNR) orders for patients from whom 
resuscitation should be withheld. In the year 
2000, the new international Resuscitation 
Guidelines were published [2]. These new 
guidelines replace lidocaine with amiodarone 
as the antiarrhythmic drug of choice in the 
treatment of shock-resistant ventricular 
fibrillation. Amiodarone is not, however, due 
to its difficulty of administration, a drug that 
is optimal for OHCA management.  
 The purpose of this thesis was to study 
different aspects of current CA management 
in Finland, in and outside the hospital, 
using definitions provided in the Utstein 
Guidelines for resuscitation research. In 
addition, this study examines the feasibility 
of using intravenous amiodarone, undiluted, 
a step saving time in OHCA management. 
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IN-HOSPITAL CARDIOPULMONARY 
RESUSCITATION – HISTORICAL 
BACKGROUND
After its description in 1960, closed-chest 
cardiac massage became the standard 
technique for maintaining circulation 
during CA, replacing open-chest cardiac 
massage [5]. In one cohort of 22 patients 
resuscitated in the surgical theatre and 
recovery room, the overall survival rate 
reached 70% [5]. When cardiopulmonary 
resuscitation was exercised on a wider scale 
in an in-hospital setting survival rates were 
considerably lower, ranging from 5 to 24% 
[16,17]. Further studies showed that patient 
selection, i.e., defining those patients likely 
to benefit from resuscitation in the hospital, 
is of great importance [18]. One such group 
was patients with myocardial infarction 
who developed ventricular fibrillation 
(VF), in whom a clear increase in survival 
rates occurred [18,19]. Cardiac Care Units 
(CCUs) and Intensive Care Units (ICUs) 
evolved to ensure that high-risk patients 
were monitored and managed in an optimal 
environment.  Nevertheless, in 1972 Lemire 
and Johnson concluded in their article with 
the provocative title “Is cardiac resuscitation 
worthwhile?”, that, despite “considerable 
endeavour in organizing resuscitation 
services in the hospital, the survival rate 
have remained fairly constant” [20]. At 
the same time, however, the proportion of 
all in-hospital deaths comprising patients 
receiving CPR had increased [12]. As a result 
of educational efforts and enthusiasm to test 
a new therapy, CPR was probably soon being 
applied to sicker and sicker patients.  
STUDIES ON IN-HOSPITAL CPR - 
VARIATION IN SURVIVAL
When reviewing studies on in-hospital CPR 
the variation in both immediate and long-
term survival rates is striking (Table 1). This 
was highlighted as early as 1972 in a study 
by Wildsmith and colleagues [21]. They 
put forward several possible explanations 
for this variation, such as differences in 
definition of CA, in hospital characteristics, 
and in successful outcome [22,23]. They 
emphasized the importance of sufficient 
study size and clear description of outcome 
[21]. Unfortunately, not until 30 years later, 
were these issues fully acknowledged when 
the Utstein Guidelines appeared [1].    
 In one study 39% of resuscitated patients 
were alive at 24 hours after the event, and 
17% survived to be discharged [24]. In 
another study the corresponding figures 
were 33% and 14%, respectively [25].  A 
review from 1989, including 44 studies, 
showed survival rates ranging from 3 to 27% 
[26].
 One large study from the beginning of the 
1990s is worth mentioning because of its 
size and the fact that it utilized a standard 
method of recording arrest variables and 
defining outcome. This study is the British 
Hospital Resuscitation Study (BRESUS), 
comprising 3765 attempted resuscitations, in 
12 UK hospitals with differing levels of care. 
Out-of-hospital onset of the arrest occurred 
in 927 of these 3765 patients. Among the 
patients with IHCA, return of spontaneous 
circulation (ROSC) was achieved in 39%, 
28% were alive at 24 hours, 17% survived to 
hospital discharge and 12.5% were alive at 
one year after the arrest [27].   
The opinion then widely accepted was that 
the differences noted could be explained only 
by inconsistencies in inclusion criteria and 
definitions of outcome. Firstly, not all studies 
clearly define CA [28,39,42]. Secondly, the 
hospital areas included in analyses have 
differed, ranging from merely ICUs [43], to 
merely general wards [45], to general wards 
plus ICUs [31,44], to the entire hospital 
minus the emergency room (ER) [25,30], to 
the entire hospital including the ER [42]. 
– REVIEW OF THE LITERATURE – Table 1. Incidence, characteristics, and outcome after in-hospital cardiopulmonary resuscitation. CA=Cardiac arrest, GW=General 
ward, ICU=Intensive care unit, VF=Ventricular fi brillation, VT=Ventricular tachycardia. 
No of 
patients Setting and year of publication
Resuscitation 
attempted CA in GWs VF/VT Discharged Follow-up Reference
100 Finland, ICU of teaching hospital, 1967 - - 58% 27% - [19]
1 204 Canada, large teaching hospital, 1972 20% - - 19%
74% alive 
at one year [20]
1 187 Canada, teaching hospital, 1300 beds, 1980 30% 41% - 17% - [12]
1 073 USA, community and teaching hospital, 630 beds, 1981 30% 49% 54% 24%
75% alive 
at one year [24]
88 USA, general hospital, 1982 18% 35% - 14% - [28]
294 USA, teaching hospital, 1983 - 35% 33% 14%
11% 
alive at 6 
months
[25]
226 USA, teaching hospital, 966 beds, 1984 - 31% 27% 14%
10% 
alive at 6 
months
[29]
329 USA, veterans hospital, 1988 43% 35% - 7% - [30]
140 USA, tertiary hospital, 568 beds, 1989 36% - 26% 24%
20% alive 
at
3 months
[31]
94 Finland, large teaching hospital, 1989 13% 71% 24% 20% - [32]
470 USA, large teaching hospital, 1990 44% 35% 16% 15% - [33]
2 838 UK, 12 hospitals, 1992 - 48% - 20% 13% alive at one year [27]
313 USA, teaching hospital, 720 beds, 1994 22% 42% 33% 16% - [34]
773 Canada, fi ve tertiary care hospitals, 1996 - 55% 32% 11% - [35]
133 New Zealand, secondary hospital, 1998 - 48% 32% 26%
23% alive 
at one year [14]
244 Norway, teaching hospital, 900 beds, 1999 5% 100% 34% 17%
15% alive 
at one year [15]
422 Sweden, teaching hospital, 980 beds, 2000 15% 31% 51% 38% - [36]
445 USA, 863 beds, 2001 - 35% - 23% - [37]
2 181 Canada, national registry, 2001 - 55% 22% 15% - [38]
247 Canada, teaching hospitals, 1000 beds, 2002 - 100% 27% 13% - [39]
103 Taiwan, tertiary hospital, 2002 - 29% 14% 17% 4% alive at one year [40]
14 720 USA, national registry, 2003 - 32% 25% 17% - [41]
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The study population is therefore not likely 
to be homogenous, due to differences in level 
of monitoring and care provided. 
 Very few studies consider patient selection 
and the use of “do not resuscitate” (DNR) 
orders. The proportion of patients subjected 
to resuscitative measures is infrequently 
reported [24,31], but can indeed be assumed 
to be of importance [46].
          
THE IN-HOSPITAL UTSTEIN GUIDELINES 
– A CONSENSUS CONCERNING 
RESUSCITATION DEFINITIONS AND 
DOCUMENTATION
These inconsistencies were not unique 
to studies on IHCA, but to the entire 
field of resuscitation medicine [47]. The 
comparison of outcomes in studies on OHCA 
management, between different EMS was 
virtually impossible [47]. To provide a 
solution, a consensus meeting was held at 
the Utstein Abbey, in Stavanger Norway, in 
the year 1990. The results were published in 
1991 [13]. The intention was also to provide 
guidelines for reporting of IHCA, but this 
proved too ambitious. Publication of the in-
hospital Utstein Guidelines was delayed; 
they were published in 1997 [1]. 
 The in-hospital Utstein Guidelines 
selected four major categories of variables 
requiring definitions: hospital, patient, 
arrest and outcome. Much of the data 
defined was for specific purposes only, but 
the Guidelines also define the minimum data 
collected for each individual resuscitation 
attempt. Outcome is assessed by identifying 
the number discharged and the number 
alive at 6 or 12 months including functional 
and neurological outcome assessed using 
the cerebral performance (CPC) or overall 
performance category (OPC) [1]. 
 The Guidelines do not define a gold 
standard for inter-hospital outcome 
comparison. Instead they emphasize the 
importance of measuring time intervals from 
collapse to defibrillation in patients with VF 
or pulseless ventricular tachycardia (VT) 
as the initial rhythm, and to securing the 
airway and administering adrenaline for all 
other CA patients.
              
STUDIES PERFORMED ACCORDING TO 
THE UTSTEIN STYLE
The Utstein Guidelines have been applied 
mostly to retrospective cohorts. Patrick 
and Rankin collected data prospectively on 
in-hospital resuscitations in a secondary 
hospital during a one-year study, and 
presented the results with reference to 
the Utstein Guidelines [14]. They offered 
some suggestions for improvement. The 
Guidelines suggest six different options for 
the variable “initial rhythm”, inconsistent 
with the definition of a CA and with most 
resuscitation algorithms. They suggested 
that “bradycardia” and “perfusing” should 
not be included among the initial rhythms 
and conclude that collecting the gold 
standard time-intervals is probably too 
ambitious without sophisticated systems 
and extra training.
 Skogvoll and colleagues evaluated the 
Utstein template applied to a retrospective 
material comprising of CPR attempts in 
a tertiary hospital [15]. In their report, 
including those CAs managed by the 
resuscitation team outside the ICU/CCU/OR 
setting, suggests that “the actual DNR-order 
rate” will be approximately the total number 
of in-hospital deaths. They also suggest that 
immediate outcome should be defined as 
only sustained ROSC enabling transport 
to intensive care instead, as recommended 
by the Guidelines, any ROSC. They also 
quite rightly point out the inaccuracy in 
determining functional outcomes from 
hospital records alone [15].
     
RECENT STUDIES ON IN-HOSPITAL 
RESUSCITATION 
By far the best results of in-hospital 
CPR appear in a study from Sahlgrenska 
Hospital in Gothenburg, Sweden [36]. A 
large proportion of the resuscitated patients 
had VF/VT as the initial rhythm (51%), 
delay before defibrillation was short (less 
than two minutes), and survival to hospital 
discharge was unusually high (37.5%) [36]. 
Approximately 75% were alive 2 years 
after the arrest, and few of them suffered 
marked brain damage [46]. The survival 
rate of patients with an initial rhythm of 
asystole was also high (24%), compared to 
results of others [15,41]. Noteworthy is that 
the proportion of patients resuscitated in 
the ICU was low (10%), and the proportion 
resuscitated in the CCU (30%) high. Herlitz 
and colleagues suggest that their own results 
are due to efficient in-hospital resuscitation 
management with short delays and selective 
application of resuscitative efforts (of 
patients with 14% CA were resuscitated) 
[46].
 A 2003 study presenting the results of 
a national registry in the USA including 
14 720 resuscitation attempts showed a 
survival to discharge of 17%, i.e., in line 
with that of previous reports [41]. This 
study highlighted the fact that, even though 
cardiac arrhythmia may be the precipitating 
event in many CAs, an initial rhythm of VF 
was evident in only 16%. This study also 
showed that few hospitals have employed 
in-hospital automated external defibrillator 
(AED) programs, and an AED was used in 
only 1.4% of the CA-patient resuscitations. 
IN-HOSPITAL RESUSCITATION 
MANAGEMENT – THE IMPORTANCE OF 
ORGANIZATION
Organizing resuscitation services outside 
the hospital has made possible a substantial 
elevation in survival rates. The most 
important factors are nicely described by the 
metaphor “the chain of survival” drafted in 
the early 1990s [11]. Embodied in “the chain 
of survival” are early access, early CPR, 
early defibrillation, and early advanced care. 
The situation, despite the lack of specific 
studies pointing out the connection between 
delay and survival in hospitals, is analogous 
in the in-hospital setting [48,49].
 In 1987, the Royal College of Physicians 
presented guidelines for organization in the 
hospital of management of and training for 
CPR [50]. Perhaps most importantly, they 
underlined the importance of appointing 
a Resuscitation Training Officer to be in 
charge of training and equipment. McGowan 
and colleagues showed a significant increase 
in survival rates from ventricular fibrillation 
through the efforts of such an officer [51]. 
 Deficiencies in resuscitation skills exist 
among nurses [52,53], physicians [54] 
and even anaesthesiologists [55]. One 
recent study suggests that it is difficult for 
physicians, excluding those in emergency 
medicine, to correctly recognize and diagnose 
a patient in CA [56]. Even physicians 
performing on-call duties in a large teaching 
hospital have lacked in knowledge of 
resuscitation algorithms [57]. 
 Whether outcomes can be improved with 
increased training of hospital personnel has 
not, however, been thoroughly evaluated. 
Organised resuscitation training is clearly 
effective, i.e., skills after training are better 
than those before training [58-60], but in 
order to retain these skills, training has to be 
regular [61]. Survival to discharge has been 
higher in those CAs discovered by nurses 
trained in advanced cardiac life support 
(ACLS) [62]. Such training of nurses, in 
another study, led only to increase in initial 
survival [63]. 
 Because rapid defibrillation is of major 
importance in the in-hospital setting as 
well as out-of-hospital [64], it would be 
helpful to have defibrillation performed 
by non-physicians [65,66]. This is, in fact, 
recommended by the major resuscitation 
councils [2]. Some problems are, however, 
associated with programs endorsing rapid 
defibrillation by nurses [67]. With appropriate 
training, nurses can perform defibrillation 
in CA, but, when not under supervision they 
seem to perform it reluctantly, meaning that 
early defibrillation, before the arrival of a 
resuscitation team, is often not successful 
[67]. 
 Wider implementation of AEDs might offer 
a solution [49]. Nurses can, in a short period 
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of time learn to use AEDs and skill retention 
seems to be good [68]. Those trained in 
BLS can often use AEDs in a simulated CA 
situation, even without prior training [69]. 
The recently enhanced level of education and 
skill among nurses has led to a more positive 
attitude towards defibrillation, making 
them willing to accept a more prominent 
role in resuscitation [70,71], but studies 
investigating the implementation of AEDs in 
the in-hospital setting and whether this can 
improve outcome are lacking.  
  Many hospitals manage CAs outside 
non-critical care areas with resuscitation 
teams. Because the impact of a resuscitation 
team on outcome is obviously dependent on 
various factors, the impact, if any, is difficult 
to determine. In one study most survivors, 
had ROSC achieved before the arrival of 
the resuscitation team, underlining the 
importance of actions taken by hospital staff 
on scene [72]. 
The promptness of the arrival of the 
resuscitation team is important. It has even 
been suggested that in hospitals where 
the delays to arrival of the team are short, 
no additional benefit would result from 
deploying an AED program on the wards 
[15]. All in all, the resuscitation team is of 
great importance in the post-ROSC period, 
stabilizing the patient and providing 
transport to intensive care [72]. 
HOSPITAL AND PATIENT 
CHARACTERISTICS PREDICTING SURVIVAL 
AFTER IN-HOSPITAL CPR – WHEN AND 
WHERE TO START, NOT TO START, AND 
WHEN TO STOP? 
Several studies have described demographic 
and clinical variables associated with 
outcome after in-hospital CPR. A lower 
likelihood of survival is associated with 
unwitnessed arrest [30,39], initial rhythm 
other than VF/VT [37,73,74], and duration 
of resuscitative efforts exceeding 15 minutes 
[33,45]. The presence of the following 
co-morbid conditions predicts mortality: 
pneumonia [44,75], sepsis [34,75], cancer 
[30,37], neurologic disease [25,76], and renal 
failure [31,77]. Analogously, the presence of 
cardiac disease [77,78] and infectious disease 
[37], predicts survival. 
 Poor pre-arrest functional capacity 
predicts mortality [25,34]. The question 
whether old age alone predicts mortality is 
not clear, with some studies supporting this 
assumption [73,77] and some contradicting 
it [79,80]. The situation regarding gender 
is similar, with some studies suggesting an 
association between gender and mortality 
[73,78] and some not [33,81].
 The issue of whether outcome is better 
at certain hospital locations is also unclear. 
Some studies have suggested that the 
outcome of CA is better in wards with a 
higher surveillance level [82,83] but others 
have failed to support such a finding 
[29,81]. Unsurprisingly, patients with a CA 
occurring during the night-time are less 
likely to survive, perhaps due to fewer staff 
and longer delays [39]. A meta-analysis, 
including 41 studies, performed by Ebell and 
colleagues in 1998 [84], nicely condenses the 
most important findings (Table 2).
 Decision aids developed to help the 
clinician decide whether resuscitative efforts 
should start and when cease in the in-
hospital setting are, however, difficult to use 
at bedside, and are not applicable in general, 
because they have been validated in rather 
distinct and small populations [85,86]. An 
exception is a clinical decision aid developed 
by van Walraven and colleagues (Table 3) 
[87]. Validated in a large cohort consisting 
of 2 181 IHCAs it quite accurately identifies 
those patients, with CA occurring on the 
GWs, that have some chance of survival to 
hospital discharge [88]. These characteristics 
are: 1. Witnessed arrest 2. Initial rhythm 
VF or VT 3. Return of pulse during first 10 
minutes of chest compression.
POST-RESUSCITATION CARE
After ROSC, cardiovascular and haemo-
dynamic derangements are common [2]. 
The goal is, thus, to provide haemodynamic 
and respiratory support, neuroprotection 
and temperature regulation, and to treat 
metabolic among other disturbances [2]. 
Most deaths of patients resuscitated outside 
the hospital are due to brain damage, i.e., 
hypoxic-ischaemic-encephalopathy (HIE) 
and only a small proportion to myocardial 
damage alone [89]. The beneficial effects of 
mild therapeutic hypothermia have been 
conclusively shown in two randomized 
clinical studies [90,91]. Several other 
aspects of post-resuscitation care have been 
studied extensively, but in few randomized 
clinical studies [2]. Most recommendations 
on post-resuscitation care are thus derived 
from animal studies and retrospective 
epidemiological studies. 
   Two recent Scandinavian studies show 
that post-resuscitation care may indeed 
have an effect on survival after CA. In the 
first study, Engdahl and colleagues were 
able to point out a difference in long-term 
mortality among patients, with equal 
baseline characteristics resuscitated by the 
same Emergency medical service (EMS), 
but treated at two different hospitals in the 
Gothenburg region [92]. They attribute some 
of the difference to socio-economic factors 
and to differences in the clinical state of the 
patients on admission, but suggest that the 
impact of hospital care cannot be ruled out. 
They also found differences in the proportion 
of patients being cardiologically evaluated at 
the two hospitals.            
 A similar difference in mortality appeared 
between four regions in Norway [93], in a 
study further including several in-hospital 
variables in a multiple logistic regression 
model predicting survival from OHCA. 
These data showed that, in addition to 
patient characteristics and pre-hospital 
variables, several in-hospital variables seem 
to predict survival from OHCA. These were: 
lack of seizures, mean 24-hour blood glucose 
below 10.6 mmol/l, body temperature below 
37.8 ºC, and base excess higher than -3.5 
mmol/l [93]. 
 These two studies have suggested that 
perhaps there should be a fifth link in the 
four-link “chain of survival”, i.e., hospital 
care. 
 The connection between post-ROSC blood 
pressure levels and survival is somewhat 
contradictory. Increasing systemic arterial 
blood pressure with a subsequent increase 
in cerebral perfusion has been shown in an 
experimental model of CA in dogs [94]. In 
a prospective study of patients successfully 
resuscitated from CA, a mean arterial blood 
pressure (MAP) level, exceeding 100 mmHg 
during the first two hours after ROSC, 
was associated with a more favourable 
neurological outcome than of patients with 
MAP below 100 mmHg [95]. A similar finding 
came from a large epidemiological study 
Table 2. Association between dichotomous patient characteristics, co-morbid condition, arrest variables and failure to survive to discharge 
after in-hospital cardiac arrest. Results of a meta-analysis by Ebell and colleagues including 49 articles [84]. ICU=Intensive care unit.
Studies No. of patients Odds ratio for failure to survive (95% CI)
Patient variables
   Age > 70 12 3 288 1.45 (1.07-1.96)
   Dependent status 8 1 152 2.75 (1.24-6.10)
Co-morbid conditions
   Sepsis on day prior to resuscitation 2 427 7.83 (0.73-84.22)
   Dementia 3 760 2.71 (1.01-7.30)
   Cancer 18 3 733 2.18 (1.49-3.18)
   Metastatic cancer 10 2 367 4.79 (2.01-11.40)
   Myocardial infarction 12 2 201 0.70 (0.49-0.99)
   Coronary artery disease 10 2 450 0.41 (0.27-0.62)
   Hypertension 3 505 0.48 (0.28-0.84)
   Serum creatinine > 220 µmol/l 3 1 146 3.14 (1.13-8.72)
Arrest variable
   Location of arrest ICU 10 4 184 0.72 (0.43-1.21)
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comprising of 1 234 patients [96]. A recent 
study with survivors of CA monitored in a 
very invasive fashion by pulmonary artery 
catheters showed that haemodynamical 
instability is common after CA but is not 
predictive of survival or of neurological 
recovery [97].
 Animal studies show the detrimental 
effects of hyperglycaemia in global ischaemia 
[98,99]. Hyperglycaemia at hospital 
admission also predicts mortality in stroke 
[100,101], myocardial infarction [102,103], 
acute coronary syndromes [104], trauma 
[105], and even among patients admitted to 
a GW irrespective of cause [106].
 Among CA patients, hyperglycaemia 
has been associated with poor neurological 
recovery and mortality [107], but this has 
largely been explained as being a surrogate 
parameter for long delay to ROSC [108]. 
One possible explanation may be the 
use of adrenaline (epinephrine), which 
causes hyperglycaemia [109], and when 
used pre-admission has been associated 
with a decreased chance of survival [110]. 
Hyperglycaemia during the first 24 hours 
after a CA independently has predicted 
a less favourable neurological recovery 
independent of pre-hospital characteristics 
[111].  
 Despite the fact that the deleterious 
effects of hyperglycaemia are evident, only 
recently did a study verify that mortality can 
be reduced among critically ill patients by 
avoidance of hyperglycaemia [112]. In that 
study, mortality among surgical patients was 
lower when normoglycaemia was maintained 
with insulin. Normoglycaemia and not the 
magnitude of insulin treatment seemed to 
explain this reduction in mortality. [113]. 
    
DO NOT RESUSCITATE ORDERS AND 
LIVING WILLS – ISSUES OF ETHICS
CPR, in the case of CA, may be inappropriate 
in clinical situations including medical 
futility and for patient wishes. In such 
cases, the patient may be designated “do not 
resuscitate” (DNR). During the last decade 
one suggestion is that “do not resuscitate” 
should be replaced with “do not attempt to 
resuscitate” (DNAR) to better describe the 
fact that CPR is a mere attempt, with a 
limited chance of success (The term DNAR 
will replace DNR throughout the remainder 
of this thesis) [114]. A decision to withhold 
CPR is exceptional because it has to be 
made beforehand, i.e., before the event has 
occurred. Without a DNAR order, the staff 
can be anticipated to start CPR even when 
it is not the best choice [115], making, 
communication among the staff and uniform 
documentation important.
 DNAR orders are frequently used for 
terminally ill patients [116-118], and 
are often a step towards palliative care 
[119,120]. The present guidelines underline 
the importance of patient autonomy, but 
crucial decisions are often made when the 
patient is unable to communicate [119,121]. 
A Dutch survey showed that most hospitals 
have a DNAR policy, but few have written 
guidelines [122]. The proportion of patients 
designated DNAR among those left without 
resuscitation is included in the Utstein 
template for reporting of IHCA [1]. Even so, 
it is seldom reported [14,15].
 In Finland, a living will is a request, 
usually written by the patient to stop 
treatment likely to prolong his/her life but 
no to improve the physical condition. The 
Ministry of Social Affairs and Health, as well 
as some patient organizations, has provided 
such written forms. A debate over the living 
will is that it has had, according to some 
international studies, only a limited effect on 
patient care [123,124].  
  FUTURE PERSPECTIVES – FROM 
TREATMENT TO PREVENTION?
Several studies have shown that patients 
experiencing CA in the hospital often have 
warning symptoms [125-127]. It would there-
fore be an appealing option to intervene 
before the patient suffers a CA. This view 
has resulted in an extension of tasks 
under taken by the resuscitation team from 
merely treating the arrest to preventing it 
[72]. In Australia, where this has received 
much attention, the resuscitation teams are 
called medical emergency teams (MET). The 
implementation of a MET has been shown 
to reduce the incidence of CA on the wards 
[128,129]. Whether it leads to any decrease 
in overall hospital mortality remains to be 
determined.
USE OF AMIODARONE IN SHOCK-
RESISTANT VF AND PULSELESS VT
Because the value of few drugs used during 
CA is supported by strong evidence, drug 
administration must be secondary to other 
interventions such as defibrillation, chest-
compressions, and airway manage ment 
[2]. The Resuscitation 2000 Guidelines 
recommend that if three shocks fail to 
restore a stable perfusing rhythm, it is 
reasonable to administer a pharmacological 
adjunct [2]. Especially in cases with a 
transient return of a stable rhythm that 
cannot be retained should an antiarrhythmic 
agent be considered [2]. However, there is no 
definite evidence indicating any long-term 
benefit with any used antiarrhythmic agent 
in resuscitation [38]. 
 Several drugs have been used. Lidocaine 
was beneficial in initial studies performed 
in animal CA models [130,131]. In one 
retrospective clinical study, lidocaine 
improved survival to hospital admission 
[132]. In a randomized comparison of 
lidocaine and adrenaline, lidocaine was 
associated with a higher incidence of 
asystole and no difference in achievement of 
ROSC [133]. The use of lidocaine is, however, 
justified because of widespread experience, 
few side-effects, and availability [2]. 
 No published studies exist on the use 
of beta-blocking agents in VF. However, 
the American Hearts Association´s (AHA) 
resuscitation guidelines from 1992, 
suggest beta-blocking agents as a possible 
pharmacological adjunct in treatment of 
shock-refractory VF. Inspired by this, the 
Helsinki EMS, in its CA treatment protocol, 
replaced lidocaine with metoprolol. Results of 
CA management in Helsinki have generally 
been good [134,135], but how much of this is 
due to the use of metoprolol is impossible to 
determine.    
 Recent studies have supported the 
use of amiodarone [136,137], a potent 
antiarrhythmic agent, originally classified 
as class III by the Vaughan-Williams criteria 
[1]. Intravenous amidarone exerts its 
antiarrythmic effects by three mechanisms. 
Firstly, it inhibits cellular sodium channels 
[138], especially in the ischaemic myocardium 
[139]. Secondly, it reduces the intracellular 
calcium concentration, probably by blocking 
calcium channels [140]. And finally, indirect 
evidence from animal studies indicates an 
antiadrenergic effect [141]. Amiodarone is 
beneficial in the treatment of life-threatening 
arrhythmias because of rapid onset of action 
and electrophysiological effects [142].         
 In a randomized clinical study, amiodarone 
proved superior to lidocaine in achievement 
of ROSC and survival to hospital admission, 
but not to survival to hospital discharge 
[136]. Problems exist, however, especially 
in the pre-hospital setting. Due to its 
vasodilatory effects, it causes hypotension 
and bradycardia, potentially harmful during 
a CA [143,144]. It is also rather expensive, 
compared to lidocaine, and is recommended 
to be diluted before administration. Dilution 
cannot be made beforehand, because 
of deterioration of the pharmacological 
compound, rendering it sub-optimal for 
the pre-hospital setting. Use of undiluted 
amiodarone has been associated with more 
aggravated side-effects, such as hypotension, 
and peripheral phlebitis (Cordarone IV. 
Prescribing Information).   
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The aim of the present study was to 
analyze current in-hospital resuscitation 
management, organization, and resuscitation 
training in Finnish hospitals and to analyze 
the overall outcome and certain outcome-
related factors for resuscitated patients with 
special reference to the Utstein Guidelines 
and the Resuscitation 2000 Guidelines. The 
specific objectives can be outlined as follows:
STUDY SETTING AND DESIGN
Finland, with a population of approximately 
5.2 million distributed over an area of 337 
000 km², provides its citizens with free 
health-care covered by the community 
health insurance scheme. In the year 2000, 
life expectancy averaged 74 years for men 
and 81 years for women, with diseases of the 
circulatory system the most common cause 
of death as well as the most likely cause for 
hospital admission [145].
 The national hospital network is three 
tiered based on the level of care provided. 
The 28 district general hospitals constitute 
the primary, the 15 central hospitals the 
secondary, and the five university hospitals 
the tertiary level (Table 3). All hospitals 
undertake acute care activities. In general, 
the primary hospitals provide general 
internal and surgical medical services and 
in some cases gynaecologic and paediatric 
– AIM OF THE STUDY – – MATERIALS AND METHODS –
services. The secondary hospitals provide, in 
general, this care as well as more specialized 
care such as intensive care and neurology, 
but excluding neuro- and cardiac surgery. 
The tertiary level includes all medical areas. 
The total number of hospital care days was 
5.3 million in the year 2000 [145].
 Helsinki the capitol city of Finland, had a 
population of approximately 560 000 in 2002. 
The Helsinki EMS is a three-tiered medical 
system responsible for medical emergencies 
in the Helsinki area. The first tier consists 
of seven ambulances and eight fire engines 
staffed with emergency medical technicians 
capable of defibrillation. Four advanced 
life-support units manned with paramedics 
make up the second tier. The third tier is 
a physician-staffed mobile intensive care 
unit. Successfully resuscitated patients are 
referred to one of the two secondary hospitals 
or to one tertiary hospital. All hospitals 
have anaesthesiological services around 
Table 3. Division of acute care hospitals in Finland based on level of care provided and the average number of beds in the year 2000. 
CCU=Cardiac care unit, ICU=Intensive care unit.
Hospital variable District  (primary) Central (secondary) University (tertiary)
No. 26 15 5*
Beds (range) 138 (54-426) 375 (155-916) 1010 (855-1200)
Surveillance beds (range) 6 (3-7) 5 (4-6) 10 (1-30)
Emergency ward beds (range) 7 (3-8) 12 (4-30) 14 (12-25)
CCU beds (range) 4 (2-6) 6 (3-10) 7 (5-10)
ICU beds (range) - 7 (4-11) 22 (4-46)
*The nine hospital units of Helsinki University Hospital, which involve emergency medicine activity, were considered for the study (tertiary 
hospital).
1. To describe the current organization of 
CPR training and in-hospital resuscitation 
management in Finnish hospitals of different 
levels of care (I).
2. To evaluate the use of in-hospital 
Utstein Guidelines in reporting outcomes of 
in-hospital CPR including the use of DNAR 
orders in four secondary hospitals (II-III).
3. To analyze the feasibility of and 
experiences with pre-hospital use of 
undiluted amiodarone and to evaluate in-
hospital post-resuscitation care of patients 
admitted alive after OHCA (IV-V).
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Table 4. Brief description of individual studies comprising the present thesis. CA=cardiac arrest, CPR= Cardiopulmonary resuscitation, 
EMS=Emergency medical service, OHCA=out-of-hospital cardiac arrest.
Study I Study II Study III Study IV Study V
Study 
aim
To describe the 
present status of in-
hospital resuscitation 
management in Finnish 
hospitals  
To evaluate the 
Utstein Guidelines in 
data collection on CA 
management
To scrutinize the use of 
DNAR orders among 
patients suffering CA 
with no CPR initiated
To address 
the feasibility 
of undiluted 
amiodarone 
in OHCA 
management 
To evaluate the 
impact of post-
resuscitation care 
on survival after 
OHCA
Design Cross-sectional mail survey Prospective study Prospective study
Retrospective 
chart analysis
Retrospective chart 
analysis
Setting All public Finnish hospitals
Four Finnish 
secondary hospitals
Four Finnish 
secondary hospitals
Patients 
resuscitated 
by the Helsinki 
EMS 
Patients 
hospitalized after 
OHCA in Helsinki
the clock. In the tertiary hospital, invasive 
cardiologic interventions and surgical 
treatment, such as coronary angiography, 
percutaneous coronary intervention (PCI), 
and coronary artery bypass grafting (CABG) 
are available.
 The setting and design of the five 
individual studies, of which this thesis is 
comprised, are outlined in Table 4.
DATA COLLECTION
CPR management in Finnish 
hospitals (I)
The status of CPR management in Finnish 
acute care hospitals was studied by a cross-
sectional mail survey in the summer of 2000. 
A questionnaire developed by the authors 
was addressed to the chief of anaesthesiology 
of the respective hospitals, who responded 
or passed it on to the respondent most 
appropriate. The questionnaire included 
133 questions about the hospital and about 
in-hospital CPR organization. It outlined 
in detail factors such as CPR training, 
including training in BLS and ALS, and 
training equipment such as CPR manikins. 
Local CPR organization included use of 
resuscitation teams and the implementation 
of rapid defibrillation. Each hospital´s policy 
on use of DNAR orders was included.   
Evaluation of in-hospital Utstein 
style guidelines (II) 
To evaluate the in-hospital Utstein 
Guidelines, a prospective study was 
undertaken at four Finnish secondary 
hospitals during the years 1999 to 2001. 
Etelä-Karjala Central Hospital (EK-CH), 
Jyväskylä Central Hospital (J-CH, officially 
called Keski-Suomi Central Hospital), 
Päijät-Häme Central Hospital (PH-CH) and 
Vaasa Central Hospital (V-CH) participated 
(Study II, Table 1). The study was approved 
by the ethics committees of all the respective 
hospitals and by the Ministry of Social 
Affairs and Health for gathering the follow-
up data.      
 Some differences existed in resuscitation 
management and CPR training between 
hospitals (Table 5). None had previously 
performed systematic data collection on 
resuscitation attempts. 
A slightly modified translated version 
of the resuscitation data collection form, 
recommended by the Utstein guidelines was 
used. During the study, an effort was made 
to collect all the recommended hospital, 
patient, CA, and outcome variables. The 
outcome of CA was presented on the 
appropriate templates recommended in the 
Guidelines [1].  
 The study was coordinated on site 
by an appointed physician and a nurse. 
Table 5. Cardiopulmonary resuscitation (CPR) training, cardiac arrest (CA) management, and “do not attempt to resuscitate” (DNAR) 
policies in study hospitals (II-III). AED=automated external defi brillator, ALS=advanced life support, CCU=Cardiac care unit, EK-
CH=Etelä Karjala Central Hospital, ICU=Intensive care unit J-CH=Jyväskylä Central Hospital, PH-CH=Päijät Häme Central Hospital, 
V-CH=Vaasa Central Hospital   
Characteristic EK-CH J-CH PH-CH V-CH
Resuscitation training
Resuscitation manager Yes Yes No No
ALS training for all nurses Yes Yes No No
ALS training for all doctors Yes Yes No No
Defi brillation training mainly for nurses 
in CCU/ICU Yes Yes Yes Yes
Method of alarm
   Pager device Yes Yes No Yes
   Mobile phone No Yes Yes No
Resuscitation team Yes No No No
Resuscitation equipment
   available on wards Yes Yes Yes Yes
Defi brillator
   Manual Yes Yes Yes Yes
   AED No Yes* No Yes
DNAR
   Policy Yes Yes Yes Yes
   Uniform style of charting No No No No
Resuscitation can be withheld without a 
DNAR order Yes Yes Yes Yes
*During part of the study period.
Resuscitation forms were sent to a 
research assistant who entered them into 
a computerized data base. Outcome was 
determined from the hospital charts or by 
personal contact by the in-hospital physician 
on location.  The OPC-category score 
served for assessing functional status and 
neurological recovery after the arrest (Table 
6). The Utstein Guidelines also recommends 
recording the cerebral performance category 
[1], but in this study OPC alone was used, 
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because it includes both cerebral and 
non-cerebral status and is therefore a 
measurement of overall performance.   
Implementation of DNAR orders in 
four Finnish secondary hospitals (III)
Simultaneously with the study of 
cardiopulmonary resuscitation, as outlined 
above, the DNAR practice and the use of 
living wills in these hospitals underwent 
study. All hospitals reported having a DNAR 
policy, but none had written guidelines or 
an official mode of documentation (Table 
5). For all patients who during the study 
period, without resuscitation, a special form 
was completed, including demographic data, 
functional status before arrest, data on 
significant medical conditions, the reason for 
hospital admission, and length of hospital 
stay. The functional status of the patients 
prior to the arrest was assessed by OPC-
category (Table 6). The form also described 
factors concerning the DNAR order, who 
assigned it, when it was assigned and 
who was consulted. The hospital charts 
of all patients who died without a DNAR 
order were rechecked, with an attempt to 
determine why CPR was not initiated in 
patients that suffered CA but had no DNAR 
order. Patients with a DNAR order were 
compared to those who died without a DNAR 
order and those who were resuscitated 
(excluded in comparison of assumed cause 
of death), when appropriate. In addition, 
patients who had unwitnessed CA on the 
GWs, but were not resuscitated, were 
compared to those who had unwitnessed CA 
on the GWs, but were resuscitated.  
Use of undiluted amiodarone in 
OHCA (IV)   
The Helsinki EMS implemented the 
Resuscitation 2000 guidelines into the CA 
treatment protocol in October 2000 [2]. The 
main difference from the former Guidelines 
was that amiodarone replaced metoprolol as 
the antiarrhythmic adjunct in resuscitation. 
Accordingly, after three ineffective 
shocks, one sequence of cardiopulmonary 
resuscitation (CPR), and administration of 
1 mg of adrenaline (epinephrine), a bolus of 
300 mg of amiodarone (Cordarone® Sanofi-
Synthelabo) was administered. Unlike in 
previous studies and Guidelines, amiodarone 
(50 mg/ml) was administered as a bolus 
without dilution, within a few seconds, into a 
vein located as centrally as possible (external 
jugular or antecubital vein). This was done to 
save time, because the dilution process in 5% 
glucose had been tested and found to take 
approximately 90 seconds. To reduce the 
hypotensive effects of amiodarone, a rapid 
intravenous (i.v.) bolus of approximately 200 
ml of acetated Ringer´s solution was given 
an amount chosen because CAs with VF or 
VT are seldom associated with hypovolemia 
and, in accordance with the guidelines, the 
patient had already received adrenaline, 
a vasopressor. If still in VF after three 
sequences of CPR, an additional dose of 150 
mg amiodarone was administered. The same 
treatment protocol was applied if, in patients 
with asystole or pulseless electrical activity 
(PEA) as the initial rhythm, VF developed 
during resuscitation. Blood pressure was 
measured immediately after ROSC was 
achieved and thereafter every 5 minutes, by 
noninvasive oscillotonometry.    
 Helsinki EMS defines systolic arterial 
blood pressure (SAP) below 120 mmHg as the 
lower level of hypotension, i.e., on a somewhat 
higher level than usually recommended [2]. 
For hypotension, intravenous dopamine 
infusion was started preadmission with an 
initial dose of 10 µg/kg/min. If the patient 
did not respond to dopamine, adrenaline 
infusion was considered. Bradycardia was 
defined as heart rate below 45/min. In 
case of bradycardia, atropine (1 mg) was 
administered. When indicated, external 
transcutaneous pacing was used in the 
treatment of atrioventricular block or 
bradycardia. Successfully resuscitated 
patients were admitted to one of three 
community hospitals in the Helsinki area. 
Outcome of patients with asystole and 
PEA as their initial rhythm who received 
amiodarone was also a focus.
Impact of hospital care on survival 
after OHCA (V)
In order to evaluate the impact of hospital 
care after OHCA the ambulance and 
hospital charts were studied of patients 
successfully resuscitated from OHCA and 
treated at one of three hospitals in the 
Helsinki area during a three year period. 
Emphasis was placed on the first 72-hour 
period of hospital care by dividing it into 18 
four-hour periods. The decision was to study 
variables either associated with outcome 
from OHCA in previous studies, parameters 
included in the Apache II scoring system 
[146], or parameters based on clinical 
judgement. Patient characteristics such as 
age [89,147,148], gender [149], prior medical 
condition [148,150], and functional capacity, 
i.e., OPC-category, were estimated from 
the hospital charts [151]. The pre-hospital 
variables included were: bystander-initiated 
CPR [152], delay to BLS [153], delay to ALS 
[154], delay to ROSC [155], and pre-hospital 
medication administered such as adrenaline 
[110] and thrombolytics [156]. Most of these 
are also included in the Utstein Guidelines 
for OHCA [13].
For each 4-hour period after hospital 
admission the following clinical parameters 
and laboratory findings were identified: 
arterial blood pressure [95,97], arterial 
blood gases [157,158], blood sugar [108,111], 
plasma (serum) sodium and potassium 
[146] and body temperature [93]. Because 
it was likely that not all values would be 
available for all periods, the mean value 
was calculated for the 72 hour period. It 
was also determined whether the patient 
received haemodynamic pressor agents, 
antibiotics, beta-blocking agents, sedation, 
or anti-arrhythmic agents, or whether head 
elevation was maintained. Examinations 
and treatments performed during the same 
hospital stay were also studied, i.e., coronary 
angiography, PCI, CABG, or the insertion 
of an implantable defibrillator. These were 
not, however, included in the study model. 
The endpoint of the study and the multiple 
logistic regression models were outcome at 6 
months following the event.    
STATISTICAL METHODS
Statistical analysis was performed by the 
author with SPSS 10.0.07 software (PC). 
Descriptive statistics of continuous variables 
are given as the mean (II-V), median (II, IV, 
V), range (II) and interquartile range (IQR) 
(IV, V). The chi-square and Fisher´s exact 
test were used for comparing categorical and 
the Mann-Whitney U test for non-categorical 
data (II-V). Correlation was tested with the 
non-parametric Spearman´s Rank correlation 
test (V). Variables with a p-value below 0.10 
in univariate analysis were included in a 
multiple logistic regression analysis with 
forward selection. Several logistic regression 
models were fitted in order to identify 
additional variables associated to outcome 
(II, III), and to determine the relative and 
independent contribution of significant 
variables to outcome (V). Discriminative 
power of significant prognostic factors 
was visualized with receiver-operating 
characteristics (ROC) curves, including the 
area under the curve (AUC), indicating 
the diagnostic ability of the test with 
corresponding 95% confidence intervals (V). 
ROC curves make the diagnostic ability of 
predictive tests visible. A two-tailed p-value 
below 0.05 was considered significant.
Table 6. Overall performance category (OPC) for assessment 
of functional capacity [13].  
OPC-1 Good overall performance
OPC-2 Moderate overall disability
OPC-3 Severe overall disability
OPC-4 Coma, vegetative state
OPC-5 Death
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IN-HOSPITAL RESUSCITATION 
MANAGEMENT AND TRAINING (I)
Of the 59 hospitals, 55 (97%) replied with 
completed questionnaires and were included 
in the study. The hospitals were analyzed in 
groups based on the level of care provided.  
Training in CPR
Of these hospitals 72% reported having an 
appointed physician or nurse in charge of 
organising in-hospital CPR training and 
maintaining CPR equipment. Most hospitals 
had organised CPR training in a centralised 
fashion with keypersons on each ward. 
Training emphasised BLS instead of ALS, 
as shown in Study I, Table 1. Manikins for 
BLS training were more common than for 
ALS training. Nurses seemed to receive 
more training than physicians, both in BLS 
and in ALS regardless of hospital level. 
Most hospitals offered physicians some 
training in defibrillation, with physicians 
in the secondary care hospitals most likely 
to receive defibrillation training regularly, 
and a similar trend was evident for nurses. 
Half the hospitals supervised resuscitation 
skills.  Most respondents (75%) reported 
that their in-hospital resuscitation training 
was insufficient.   
 
CA recognition and alarm systems
A majority of the hospitals had written 
algorithms for recognition of a CA and for 
BLS. The most common means for CA alerts 
was by telephone either to a mobile phone 
or to a pager. The tertiary hospitals used to 
some extent loudspeaker alerts in addition 
to telephone paging. 
– RESULTS –
Defibrillators and defibrillation 
All hospitals reported having defibrillators 
located in the CCU and ICU and in 
the ER. Concerning the GWs, the most 
common practice was to have defibrillators 
located between wards (Study I, Table 2). 
Independent of level 40% of hospitals used 
AEDs. An average of 10% of hospitals, 
regardless of level, intended to obtain AEDs. 
Of the secondary 27%, of the primary 19% 
and none of the tertiary hospitals had 
decided against obtaining AEDs. The matter 
had not been considered in 31% of the 
tertiary, 20% of the secondary, and 33% of 
the primary hospitals.
 Half the hospitals, more commonly among 
secondary and the tertiary level, reported 
that the nurses in the CCU and ICU were 
likely to perform defibrillation before the 
arrival of a physician. Concerning the GWs, 
the corresponding figure was 15% (Study I, 
Table 2).  
Advanced life support and 
resuscitation teams
In the primary hospitals, resuscitation was 
managed by the ward physician and by 
the anaesthesiologist on call. Few primary 
hospitals had resuscitation teams. Half the 
primary hospitals had occasionally been 
using the pre-hospital emergency medical 
services for IHCA. Half the secondary 
hospitals managed CAs with a resuscitation 
team comprising an anaesthesiologist and 
a nurse from the ICU or the ER. In those 
secondary hospitals without a resuscitation 
team, CA was managed by the ward 
physician and the anaesthesiologist on 
call. The majority of the tertiary hospitals 
managed CAs with resuscitation teams.   
Guidelines, data collection, 
time intervals, and measures of 
improvement
About 60% of the hospitals had ALS 
guidelines, the ERC guidelines being the 
most common, followed by guidelines of 
the AHA. A few hospitals had modified 
guidelines of their own. A majority of 
hospitals used a resuscitation-data-
collection form. Half the hospitals performed 
data collection but only a few by the Utstein 
Guidelines; 30% of hospitals had measured 
IHCA time-intervals. No large differences 
between hospitals of different levels of care 
emerged in quality assurance, in checking 
resuscitation forms or providing feedback 
to those involved. Such practices occurred 
in approximately half the hospitals. A 
larger proportion of the secondary hospitals 
(87%) than primary (50%) or tertiary 
ones (54%) reported taking measures to 
improve resuscitation training. Of the 
secondary 67%, of the primary 63%, and of 
the tertiary hospitals 62%, were planning 
to take measures to improve resuscitation 
management in the near future.
DNAR  orders
The majority of the hospitals reported 
having a DNAR policy, but few used 
a unified notation style. The hospitals 
reported that resuscitative efforts could be 
withheld without a DNAR order based on 
a decision by the on-site physician. A few 
hospitals reported that resuscitation efforts 
could be withheld without a DNAR order if 
the attending nurse considered the situation 
futile. A larger proportion of the primary 
(33%) and secondary hospitals (27% than 
of tertiary hospitals (15%) reported such a 
practice. 
 
CPR IN FOUR SECONDARY HOSPITALS 
ACCORDING TO UTSTEIN GUIDELINES 
(II-III)
During the study period, a total of 1 
691 patients had a CA. Resuscitation 
was attempted in 205 (12%) (Template 
presentation, Appendix 1). One patient 
was excluded from the analysis due to 
insufficient data. The total number of 
resuscitation attempts was 208, because two 
patients arrested more than once. Only the 
final attempt was included in the analysis, 
making 204 patients the final study figure. 
The mean age of those resuscitated was 68 
years (range 0-96), with 121 (59.3%) male 
and 83 (40.7%) female.
Collection of the Utstein parameters 
In four patients, the primary collection 
with the template form failed, so data had 
to be retrieved from case histories. The 
Utstein parameters were available from the 
resuscitation forms or from case histories 
with variable success, as shown in Table 7. 
Table 7. Proportion of Utstein variables successfully 
collected in four Finnish secondary hospitals during one 
year. OPC=overall performance category, ROSC=return of 
spontaneous circulation.
Utstein variable Proportion collected 
Arrest variables
1. Initial rhythm
2. Assumed cause of arrest
91%
97%
Treatment variables
1. ECG
2. Intubation
100%
99%
Time intervals
1. Interval to defi brillation
2. Interval to arrival of resuscitation team
3. Interval to adrenaline
4. Interval to ROSC
5. Total duration of resuscitation 
90%
78%
72%
83%
83%
Outcome variables
1. Survival to discharge
2. OPC-category at discharge
3. Discharge destination clear
4. Survival at 12 months
99%
97%
12%
99%
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CA variables
In 57 patients (28%), the initial rhythm was 
either VF or VT (Table 8), with differences 
in distribution of the initial rhythms 
within each hospital and between hospitals 
(Figures 1 and 2). VF/VT was more prevalent 
in hospital areas where patients were most 
closely monitored such as the CCU/ICU (p = 
0.001) (Figure 1). Accordingly, in the CCU/
ICU fewer patients had an undetermined 
initial rhythm than in other areas (p = 
0.001). In EK-CH, the prevalence of VF/VT 
was higher (p = 0.02), and undetermined 
Treatment variables
All patients except one were defibrillated 
by manual defibrillator. Most frequently in 
EK-CH, was defibrillation performed by a 
nurse (p = 0.04) (Figure 3). Mean interval 
to defibrillation was 3 (median 0) minutes 
in the CCU/ICU setting as compared to 
5 (median 4) minutes in other hospital 
areas. Outside the CCU/ICU, half the 
defibrillations occurred within 3 minutes 
as recommended by the Resuscitation 2000 
Guidelines [2]; the corresponding rate in the 
CCU/ICU was 80%.
Outcome variables
A ROSC exceeding 20 minutes was achieved 
in 69 patients (34%) and survival beyond 
24 hours in 44 (22%); 34 patients (17%) 
survived to be discharged, with 22 (11%) 
alive at 6 months and 18 (9%) at 12 months 
(Table 8 and Template presentation, 
Appendix 1 and 2). One patient refused to 
participate in follow-up. Of the 34 patients 
discharged, 20 had made a satisfactory 
neurological recovery (OPC 1 or 2) 
(Template presentation, Appendix 1 and 
2), with 11 showing a lower, 5 a higher and 
18 no change in OPC-category at discharge 
compared to category at admission. At 12 
months after the event, 15 patients had an 
OPC-category of either 1 or 2 (Template 
presentation, Appendix 1 and 2). Of the 57 
Figure 1. Proportion of ventricular fi brillation/ventricular 
tachycardia (VF/VT) and other or undetermined rhythms indexed 
by in-hospital location of cardiac arrest. ER=emergency room, 
CCU=Cardiac care unit, GW=General ward, ICU=Intensive care 
unit, OA=operating area.
Figure 2. Proportion of resuscitation attempts with ventricular 
fi brillation/ventricular tachycardia (VF/VT) and other or 
undetermined initial rhythms in four Finnish secondary hospitals. 
EK-CH=Etelä-Karjala Central Hospital, J-CH=Jyväskylä Central 
Hospital, PH-CH=Päijät-Häme Central Hospital, V-CH=Vaasa 
Central Hospital.
patients with VF/VT as the initial rhythm, 
ROSC exceeding 20 minutes was achieved in 
24 patients (42%), and 19 (29%) survived to 
be discharged; 8 patients (14%) were alive at 
12 months from the event. 
Factors associated with survival 
Patient variables. Patient characteristics 
such as age, gender, and OPC-category 
at admission showed no association with 
survival to hospital discharge. Neither 
Table 8. Outcomes of 204 in-hospital resuscitation attempts in percentage of number of attempts indexed by hospital, hospital 
location, and initial rhythm. CCU=Cardiac care unit, EK-CH=Etelä-Karjala Central Hospital, ER=emergency room, GW=General ward, 
ICU=Intensive care unit, J-CH=Jyväskylä Central Hospital, OA=operating area, PEA=Pulseless electrical activity, PH-CH=Päijät-Häme 
Central Hospital, ROSC=return of spontaneous circulation, V-CH=Vaasa Central Hospital, VF=Ventricular fi brillation, VT=Ventricular 
tachycardia.
Attempts ROSC> 20 min
Sustained 
ROSC>24h
Survival to 
discharge 
Alive at 6 
months 
Alive at 12 
months 
Lost for the 
follow up 
Hospital
EK-CH 41 41% 24% 22% 15% 12%
PH-CH 76 29% 13% 11% 7% 7%
J-CH 51 33% 27% 22% 14% 10% 2%
V-CH 36 36% 28% 17% 11% 8%
Hospital 
location
ER 25 36% 8% 8% 4% 4%
CCU 59 25% 19% 17% 14% 14%
ICU 51 51% 39% 26% 16% 10% 2%
OA 12 17% 8% 0% 0% 0%
GW 52 28% 17% 15% 10% 8%
Radiology 
or  laboratory 4 50% 25% 25% 0% 0%
Initial rhythm
VF 42 45% 38% 29%* 19% 17%
PEA 48 21% 10% 8% 4% 2%
Asystole 68 38% 21% 16% 9% 9% 2%
VT 15 33% 27% 27%* 20% 7%
Other 13 39%  15% 0% 0% 0%
Undetermined 18 22% 17% 17% 17% 17%
Total 204 34% 22% 17% 11%  9% 1%
*A signifi cant difference in survival-to-discharge rate between patients with VF/VT and other rhythms.
Figure 4. Survival to hospital discharge and at one year related to 
the delay to defi brillation, in minutes (data available for 51/57), in 
patients with ventricular fi brillation/ventricular tachycardia as the 
initial rhythm (p = 0.019 and 0.047, respectively).
Figure 3. Proportion of resuscitation attempts with defi brillations 
performed by nurses. Signifi cant differences appear between 
hospitals in proportions of resuscitation attempts with defi brillation 
performed by a nurse (p=0.04). EK-CH=Etelä-Karjala Central 
Hospital, J-CH=Jyväskylä Central Hospital, PH-CH=Päijät-Häme 
Central Hospital, V-CH=Vaasa Central Hospital. 
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was the presence of cardiovascular 
disease, malignancy, respiratory disease, 
gastrointestinal disease, trauma, or 
metabolic disease predictive of likelihood of 
survival to hospital discharge.  
Hospital variables. As to outcomes of 
resuscitation occurring at the various in-
hospital locations (Table 8), resuscitations 
occurring in the ICU were more likely to 
result in ROSC (p = 0.003) but not in survival 
to hospital discharge (ns).
   
Event variables. Patients with witnessed 
CA were more likely to survive to hospital 
discharge (p = 0.05); no long-term survivors 
were among patients suffering unwitnessed 
CA. Patients with VF/VT as the initial 
rhythm were more likely to be discharged 
alive (p = 0.007) but 12-month survival 
rates were equal among those with either 
initial rhythm. In the subset of patients 
with VF/VT, the patients with a suspected 
cardiac cause of the arrest were more likely 
to survive to hospital discharge (p=0.04). In 
patients with VF/VT as the initial rhythm, 
those defibrillated by a nurse were more 
likely to survive to hospital discharge than 
those defibrillated by a physician (p = 0.017), 
but with no differences in defibrillation 
delays between these groups.      
Time intervals. Time-intervals to various 
treatments were compared between 
survivors and non-survivors; defibrillation 
delay of patients with VF/VT as the initial 
rhythm was the only significant difference. 
Among the patients with VF/VT as the 
initial rhythm, survivors had shorter 
intervals (mean 1 min, median 0 min, range 
0-6) to defibrillation (available in 51/57) 
than did non-survivors (mean 5 min, median 
1 min, range 0-25) (p=0.046 with Mann-
Whitney U). Of patients defibrillated within 
2 minutes, 15 of 36 survived compared to 1 of 
15 patients defibrillated later (p = 0.019) as 
shown in Figure 4. 
PREVALENCE OF DNAR ORDERS AND 
ADVANCE DIRECTIVES IN FOUR FINNISH 
SECONDARY HOSPITALS (III) 
During the study period, 1 486 patients had 
a CA without resuscitative measures being 
initiated. The study form was successfully 
completed for 1 143 (77%), and these patients 
were included in the study. The mean age of 
these patients was 71 years; 648 (57%) were 
male and 495 (43%) were female.
DNAR orders
Of 1 143 patients who died without 
resuscitation, 967 had a DNAR order present, 
at time of death (Template presentation, 
Appendix 1). No patients resuscitated had a 
DNAR order.
 A significant difference, in the prevalence 
of DNAR orders, appeared both between 
hospitals and between wards the hospital 
(Study III, Table 3). More patients not 
resuscitated had a DNAR order in the CCU 
(100%), ICU (87%), and internal medicine 
wards (87%) than in the surgical (80%) 
and oncological wards (69%) and in the ER 
(61%). Patients with a DNAR order were 
more likely to be older (72 vs. 68 years) and 
of poorer functional status as indicated by 
their OPC-category in than those who were 
resuscitated or who died without a DNAR 
order. Patients designated DNAR had been 
treated for a longer time than those without. 
Few patients (1.2%) had, despite the DNAR 
order, a decision to defibrillate in case of 
VF or VT. Patients with urologic (90%), 
neurologic (80%), or malignant (75%) disease 
were more likely to have a DNAR order than 
those with cardiovascular disease (68%) or 
trauma (43%) (Study III, Table 3). 
 The DNAR order was, in the majority of 
cases (data available for 943 patients) issued 
by the ward physician (usually the registrar) 
responsible for the patient´s care. The 
anaesthesiologist had actively participated 
in the decision-making in 13% of the cases 
and the relative or next of kin in 5%. The 
DNAR order was documented in the medical 
records for 568 patients and in all other 
cases in the nursing records.    
 
Living wills
At the time of death, 18 patients (1.5%) 
had a living will and all of these also had a 
DNAR order present. A slight difference in 
the prevalence of living wills existed among 
the study hospitals. There was no significant 
difference in age, patient gender or co-
morbid condition between patients with and 
without a living will.    
Patients with CA without a DNAR 
order 
For 176 patients, resuscitation was not 
initiated despite the absence of any DNAR 
order (Template Presentation, Appendix 1). 
In 117 (66%), the decision was to restrict 
treatment, but there was no record of any 
DNAR order. Most of these 117 had a 
terminal illness, and death was expected. 
Forty-seven patients suffered unwitnessed 
CA. The reason resuscitation was not 
initiated was unclear for five patients (3%). 
Hospital records were unavailable for seven 
(4%).
Unwitnessed CA on the wards
A total of 65 patients suffered unwitnessed 
CA on the wards; resuscitation was initiated 
in 18. In four patients ROSC was achieved, 
but none survived to hospital discharge. 
Patients that were resuscitated were likely 
to be of better functional capacity, i.e., with a 
lower OPC-category (p < 0.05) than those not 
resuscitated. Resuscitation was more likely 
to be initiated during duty hours (p < 0.05).     
IMPACT OF ANTIARRHYTHMIC 
TREATMENT WITH UNDILUTED 
AMIODARONE AND OF HOSPITAL CARE ON 
OUTCOME AFTER OHCA (IV-V)
Characteristics of patients receiving 
amiodarone
From 1 October 2000 to 30 September 2002, 
712 patients suffered OHCA and were 
considered for resuscitation. Resuscitation 
was initiated in 566 (Study IV, Figure 
1). Initial rhythm was as follows: 181 
(32%) patients had VF or VT, 203 (36%) 
had asystole, and 182 (32%) had PEA. Of 
patients with VF/VT, 79 (44%) received 
undiluted amiodarone in addition to other 
resuscitative measures (Study IV, Table 
1). Of the patients with asystole or PEA, 
12 (6%) and 18 (10%) received amiodarone 
in addition to other resuscitative measures 
(Study IV, Figure 2).
 As expected, patients who received 
amiodarone had a more complicated pre-
hospital course indicated by longer delays 
to ROSC, more defibrillatory shocks, and 
larger amounts of adrenaline administered 
(Study IV, Table 1). Five patients received no 
amiodarone despite having VF after the first 
3 shocks (Study IV, Table 1). In four of these, 
VF either converted into a perfusing rhythm 
(two patients) or into PEA (two patients) 
after a maximum of five shocks. One of the 
patients had suffered EMS witnessed CA in 
which, according to the treatment protocol, 
up to nine shocks are given before any other 
intervention.    
Hypotension and bradycardia after 
ROSC in patients found in VF/VT 
Post-ROSC systolic blood pressure levels 
were similar among patients who did or did 
not receive amiodarone (Study IV, Table 2). 
Highest measured diastolic blood pressure 
levels were significantly higher among 
those receiving amiodarone (median 90, 
IQR 79-98) than those who did not (median 
80, IQR 63-91) (Study IV, Table 2). The 
lowest measured pulse levels were lower 
among those receiving amiodarone (median 
60, IQR 52-77) than among those who did 
not (median 98, IQR 64-90). Requirements 
for vasopressors after ROSC, were similar 
among patients who received or did not 
receive amiodarone. 
 Seven patients received amiodarone 
during CPR but not adrenaline. These 
patients had a non-complicated pre-hospital 
course, as shown by short delays to BLS, 
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ALS, and ROSC. For two of them, EMS staff 
witnessed the arrest. Six patients achieved 
ROSC. Systolic blood pressure levels ranged 
from 80 to 112 and diastolic from 55 to 80 
mmHg during transportation to hospital.
 One patient who received amiodarone 
and two who did not required external 
transcutaneous pacing during transportation 
to hospital. One patient who received 
amiodarone developed a non-perfusing 
rhythm and required an infusion of 
adrenaline during transportation. 
Patients with PEA or asystole as the 
initial rhythm
During the resuscitative efforts 12 patients 
found in PEA and 18 found in asystole 
developed VF (Study IV, Figure 2) and were 
given amiodarone. ROSC was achieved in 
four and five, respectively. Two found in 
asystole and one in PEA, survived to be 
admitted and none to discharge.    
Outcome of patients admitted to 
hospital after OHCA
A total of 102 immediate survivors from 
resuscitation of OHCA were identified from 
the hospitals´ registries (Study V, Table 
1). The hospital charts of 98 patients were 
available and were included in the study. Of 
these, 17 (17%) were included in a study on 
the use of mild hypothermia after CA and 11 
were treated with hypothermia. In-hospital 
parameters and laboratory findings studied 
were measured with variable frequency, as 
shown in Study V, Table 2.       
 Patients surviving beyond 72 hours from 
arrest were 87 (89%) and 67(68%) to hospital 
discharge (Study V, Figure 1). Fifty-six 
patients (57%) were alive 6-months from 
the event. Ten patients (10%) were issued 
a DNAR order during the first 72 hours 
of hospital care. Thirty-one (32%) were 
examined with coronary angiography, 14 
(14%) were treated with CABG, and nine 
(9%) received an implantable defibrillator.
Figure 5. Unadjusted 6-month mortality and mean 72-hour blood 
or plasma glucose values in quartiles (22 patients per group) in 
patients resuscitated from out-of-hospital cardiac arrest, excluding 
those issued a “do not attempt to resuscitate” order.
Figure 6. Unadjusted 6-month mortality and mean 72-hour blood 
or plasma potassium values in quartiles (21-22 patients per 
group) in patients resuscitated from out-of-hospital cardiac arrest, 
excluding those issued a “do not attempt to resuscitate” order. 
Factors independently predictive 
of outcome with multiple logistic 
regression
Results of univariate analysis of variables 
on survival at 6 months after the event 
are shown in Study V, Tables 1-3. The 
correct classification rate of the multiple 
logistic regression model was 86%. Factors 
independently associated with 6-month 
survival were age, delay to ROSC, mean 72-
hour blood (or plasma) glucose concentration, 
mean 72-hour plasma (or serum) potassium 
concentration, and use of beta-blocking 
agents during post-resuscitation care. 
 From the second model were excluded 
those patients designated DNAR during the 
first 72 hours of post-resuscitation care. The 
correct classification rate fell to 70%. Age 
(p = 0.001), use of pre-hospital adrenaline 
(p = 0.03), mean plasma potassium level (p 
= 0.02), mean blood glucose level (p = 0.03), 
and use of in-hospital beta-blocking agents 
(p = 0.002) were independently associated 
with survival.
 Blood glucose level on hospital admission 
(p = 0.004) as well as the mean 72-hour 
values (p = 0.0001) correlated (Spearman´s 
Rank) with amount of pre-admission 
adrenaline. When patients designated 
DNAR were excluded from the analysis, use 
of pre-admission adrenaline was associated 
Figure 7. Unadjusted 6-month mortality and use of beta-blocking 
agents during the fi rst 72 hours of post-resuscitation care among 
patients resuscitated from out-of-hospital cardiac arrest, excluding 
those issued a “do not attempt to resuscitate” order.  
Figure 8. Unadjusted 6-month mortality and age in quartiles (24-25 
patients per group) in patients admitted alive after resuscitation 
from witnessed out-of-hospital cardiac arrest.
Figure 9. Unadjusted 6-month mortality and the interval to return 
of spontaneous circulation in quartiles (24-25 patients per group) 
in patients admitted alive after resuscitation from witnessed out-of-
hospital cardiac arrest. 
with mortality. Mortality and quartile 
group for mean 72-hour blood glucose level 
is shown in Figure 5. Receiver operating 
characteristic (ROC) curves were created for 
admission, mean 36-hour, and mean 72-hour 
blood glucose values (Study V, Figure 3).     
 Plasma or serum potassium levels were 
independently associated with mortality 
in the multiple regression models. The 
connection between mortality and of 
quartiles of the measured mean 72-hour 
potassium levels is shown in Figure 6. The 
highest mortality occurred when potassium 
levels exceeded 4.2 mmol/l. No correlation 
appeared between glucose and potassium 
levels (Spearman´s Rank).  
Use of beta-blocking agents (p=0.005) 
during the first 72 hour of post-resuscitation 
care was associated with survival in the 
multiple regression models. The majority 
(79) of the patients received beta-blocking 
agents. Mortality among those receiving 
beta-blocking agents was 29%, as compared 
to 71% among those who did not, excluding 
patients with a DNAR order (Figure 7). 
On admission, 52 patients (53%) had an 
ECG finding suggestive of either cardiac 
ischaemia or infarction. Age and delay to 
ROSC were independently associated with 
mortality in the multiple logistic regression 
models (Figure 8, Figure 9).    
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TEMPLATE PRESENTATION
Appendix 1. CA, CPR, and DNAR orders in four Finnish secondary hospitals during a one-
year period utilizing the in-hospital Utstein template (Studies II-III). 
Appendix 2. Outcome of resuscitated patients with a non-VF/VT initial rhythm in four 
Finnish secondary hospitals during one year (Study II). 
1. Patient days in the year 2000
N = 756 000
2. No resuscitation attempted
N = 1 486
Data collection successful 1 143 (77%)
Patients designated DNAR 967
Patients not designated DNAR 176
Found dead 47
Considered futile 117
No reason stated 5
Charts missing 7
4. False arrests
N = ?
3. Resuscitation attempted
N = 205
Data collection
successful in 204 (99%)
5. Non-VF/VT
N = 147
PEA, 48
Asystole, 68
Other rhythm, 13
Undetermined, 18
6. Initial rhythm VF/VT
N = 57
VF, 42
VT, 15
7. Never achieved ROSC
N = 25
8. Any ROSC
N = 32
9. Died in hospital
N = 16
ROSC < 20 min, 8
ROSC > 20 min but < 24 hours, 4
ROSC > 24 h, 4
10. Discharged alive
N = 16
Alive at 6 months, 11
11. Died within one year
after discharge
N = 2
OPC 2 (1)
OPC 3 (1)
12. Alive at one year
N = 8
OPC 1 (6)
OPC 2 (0)
OPC 3 (2)
Lost for the follow-up, 1
6. Non-VF/VT
N = 147
PEA, 48
Asystole, 68
Other rhythm, 13
Undetermined, 18
7. Never achieved ROSC
N = 82
8. Any ROSC
N = 65
9. Died in hospital
N = 47
ROSC < 20 min, 20
ROSC > 20 min but < 24 hours, 21
ROSC > 24 h, 6
10. Discharged alive
N = 18
OPC 1 (10)
OPC 3 (4)
OPC 4 (4)
11. Died within one year
after discharge
N = 8
OPC 2 (1)
OPC 3 (1)
12. Alive at one year
N = 10
OPC 1 (8)
OPC 2 (1)
OPC 3 (1)
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RESUSCITATION SELECTION AND 
OUTCOME
Survival
In the present study, 12% of in-hospital 
patients with CA were resuscitated, 
comparable to the figure (14%) from 
Sahlgrenska Hospital in Gothenburg [36]. 
The survival to hospital discharge rate 
(17%) was similar to figures reported in the 
literature, but the one-year survival rate (9%) 
was somewhat lower (Table 1). In this study, 
50% of the survivors to hospital discharge 
were alive at one year. The corresponding 
figure reported in the literature ranges from 
24 to 90% [14,15,27,40,46]. Few have studied 
the long-term survival from IHCA in detail. 
Spice and colleagues have suggested that 
patients with multiple medical problems and 
IHCA unrelated to ischaemic heart disease 
die early after hospital discharge [159]. This 
may explain part of the low one-year survival 
in the present study. 
 Patients resuscitated from an arrest with 
cardiac cause seem to survive longer [159]. 
This is also implied in a study by Huang 
and colleagues [40], in which for in-hospital 
CPR in a tertiary hospital in Taiwan, very 
few patients had an arrest due to ischaemic 
heart disease, and only 24% of those 
discharged were alive after one year, i.e. only 
4% of all those resuscitated. In the present 
study, the one-year survival of patients with 
an assumed cardiac cause for the arrest did 
not differ from others´. The one-year survival 
rate was, nevertheless, highest among those 
resuscitated in the CCU. 
Variation in CA variables and 
survival among the study hospitals
  There appeared to be some differences, 
though statistically insignificant, in survival 
between the study hospitals. The highest 
survival rate to hospital discharge and at 
– DISCUSSION –
one-year was seen in EK-CH. Interestingly, 
the incidence of VF/VT was highest and 
the incidence of “undetermined” and “other 
rhythms” was lowest in EK-CH. Some 
variability existed in IHCA management 
between the four hospitals (Table 5), which in 
theory could explain some of the differences. 
For instance, in EK-CH, resuscitations were 
handled mainly by a resuscitation team 
possibly more acquainted with diagnosing 
cardiac rhythms in emergency situations. In 
addition, in EK-CH it was more likely that 
the defibrillation was performed by a nurse. 
This might indicate that CA management 
in EK-CH, in general, had received more 
attention than in the other hospitals. On the 
other hand, a difference in the aetiology of 
these arrests cannot be ruled out.
  In the present study, the best survival 
rates occurred on wards utilizing continuous 
cardiovascular monitoring (26 vs. 10%) 
confirming findings of Herlitz and colleagues 
[160]. The present rates, however, were 
considerably lower than they reported (43 
vs. 31%), suggesting a need for further 
improvement in organization and training in 
our hospitals. The survival rates of Herlitz 
and colleagues [160], it must be noted, are 
exceptionally good compared to others´ 
[15,41,88].       
THE INFLUENCE OF INITIAL RHYTHMS 
ON SURVIVAL AFTER IHCA 
Initial rhythm VF/VT
The survival to hospital discharge rate (29%) 
of patients with VF/VT was comparable 
to those of previous reports, with survival 
to hospital discharge rates ranging from 
14 to 57% [14,15,36,40,41]. Interestingly, 
the one-year survival rate (14%), of these 
patients was somewhat lower than reported 
by others [14,15,36]. In the present study, 
patients with IHCA and VF/VT as the 
initial rhythm, compared to patients with 
other rhythms, were found more likely to 
survive to hospital discharge, but not to 
one-year after the arrest. Thus, the one-year 
mortality of patients with VF/VT was rather 
high. Moreover, the 6-month mortality 
of VF/VT patients discharged alive after 
OHCA was considerably lower than for those 
discharged after IHCA. Obviously, this may 
be due to other co-morbid conditions, but one 
may speculate whether the impact of follow-
up or preventive medical interventions 
such as PCI or placement of an implantable 
defibrillator would have improved outcome. 
Indeed most of the patients resuscitated 
from OHCA in this study were treated at a 
tertiary hospital, with these interventions 
available. Unfortunately, these issues are 
impossible to elucidate thoroughly, due to 
limited study size.     
Initial rhythm PEA or asystole
The survival to hospital discharge and 
to one year after IHCA of patients with 
asystole and PEA as the initial rhythm 
are in line with previous findings, but the 
one-year survival rate was somewhat lower 
[14,15,36,40,41]. The survival to discharge 
of patients resuscitated after IHCA with 
asystole or PEA are in general much better 
than for the respective patients resuscitated 
after OHCA [36, 134], probably due either 
to shorter delays before start of treatment 
in the hospital, or to differences in aetiology 
of the initial rhythm, as suggested by Herlitz 
and colleagues [36]. Asystole in OHCA may 
be an indication either of terminal disease or 
of long latency before initiation of BLS and 
ALS. Thus, resuscitation of IHCA patients 
with asystole or PEA as the initial rhythm 
cannot be considered hopeless, especially 
if the arrest is witnessed and treatment is 
started immediately, i.e., in the CCU/ICU 
setting. On the other hand, the survival 
of patients suffering unwitnessed CA, 
especially those with PEA or asystole as 
the initial rhythm, and occurring in the 
GWs, seems to be very low. This is nicely 
in accordance with the clinical-decision-aid 
developed by van Walraven and colleagues 
[88].             
IN-HOSPITAL RESUSCITATION 
MANAGEMENT
Training in BLS and ALS
The present study demonstrated that 
the majority of Finnish hospitals (75%) 
had appointed a person to be in charge of 
resuscitation management, i.e., performing 
duties similar to those performed by the 
Resuscitation Training Officer in the UK 
[50]. In the UK, all public hospitals are 
obliged to have an appointed Resuscitation 
Training Officer supervising and organizing 
CPR-related activities. In 2003, 60% of 
hospitals in Sweden had a service assigned 
to CPR education and other CPR-related 
activities [161]. The corresponding figures 
for other European countries are unavailable 
for comparison. The appointment of a 
Resuscitation Training Officer has enhanced 
survival rates after IHCA [51].
 Training in BLS and ALS was common in 
Finnish hospitals but was seldom regular. 
Nurses seemed to receive more training 
in ALS, than did physicians, especially in 
the primary and tertiary hospitals. Few 
hospitals supervised resuscitation skills. 
Interestingly, only 20% of the respondents 
reported that CPR training in their hospitals 
was sufficient. In Sweden a report on 
resuscitation management in hospitals 
concluded that 40% of the hospitals had 
sufficient CPR training [161]. Although the 
low frequency of organized training in BLS 
and ALS for physicians may raise some 
concern few studies address the effect of 
training in CPR in the hospital. There exists 
indication of an increase in the survival 
rate of patients resuscitated from VF/VT 
in UK hospitals, which may be linked to 
improvements in resuscitation training 
[162]. 
 Leah and Coats presented a model 
of a tiered organisation in in-hospital 
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resuscitation training in which ALS training 
was focused on junior doctors and doctors 
practising in acute medicine areas [163]. 
For other physicians, training in BLS and 
defibrillation might be sufficient. This is 
probably reasonable, especially in hospitals 
with resuscitation teams. Recent studies 
have highlighted the fact that most CA 
patients have preceding symptoms such as 
hypotension, hypoxia or a decreased level of 
consciousness [125]. The recognition of these 
patients in time allowing for intervention is 
seldom included in traditional ALS/ACLS 
courses [162].   
 In summary in-hospital CPR training 
needs to be organised, focused, and regular. 
Continuous data collection on in-hospital 
CPR attempts is the only way to identify 
the weak links in the in-hospital chain of 
survival. Resuscitation training in a hospital 
can then be designed to meet the specific 
needs of that hospital.  
Defibrillation
Delay to defibrillation was the only time 
interval shown to be of importance for 
survival of the patient in four Finnish 
secondary hospitals. Similar findings exist 
[64]. About half of the defibrillations were 
performed within 3 minutes, as recommended 
by the Resuscitation 2000 Guidelines, 
outside the CCU/ICU. This seems, therefore, 
to be the weakest link in the in-hospital 
chain of survival. At the same time, few 
hospitals (15%) have early defibrillation 
programs on GWs and only half have them 
in the CCU and ICU. Most Finnish hospitals 
have defibrillation training for some nurses, 
but in few hospitals are all nurses trained. 
It was striking that the patients with VF/VT 
as the initial rhythm who were defibrillated 
by a nurse rather than by a physician were 
more likely to survive to hospital discharge. 
One possible interpretation of this is that a 
trained nurse might indeed be more skilled 
than an untrained doctor. Still, no difference 
was seen in defibrillation latency depending 
on who defibrillated the patient.  
 Studies on CA management in the 
hospital seldom report defibrillation delays. 
In Sahlgrenska Hospital in Gothenburg, 
the median delay to defibrillation was one 
minute in the “monitored” wards (CCU, ICU) 
and 5 minutes in the “non-monitored” wards 
[160], as in the present study. Despite similar 
delays, the survival rates were significantly 
higher in Gothenburg. In the present study 
most survivors to hospital discharge and 
all survivors at one year, were defibrillated 
within 2 minutes of their arrest (42%). This 
is comparable to the early defibrillation 
rate (48%) reported by Spearpoint and 
colleagues [64]. In the present study, the 
survival to hospital discharge rates of 
patients defibrillated later than two minutes 
was low (7%), somewhat lower than that of 
(14%) Spearpoint and colleagues [64]. In 
that study as well as in the present one, 
most patients with a delay shorter than 2 
minutes suffered a cardiac arrest either in 
the CCU or ICU. Because these wards are 
designed to treat critically ill patients with 
continuous monitoring and they have more 
staff, all CA patients should be defibrillated 
without major delay, but, the impact of rapid 
defibrillation on survival, on the GWs, has 
not yet been thoroughly elucidated.
 Herlitz and colleagues have reported 
high survival rates for in-hospital VF/VT 
patients despite the fact that defibrillation 
was later than 5 minutes from the arrest 
[36]. Thus a shorter interval cannot entirely 
explain these differences in survival. Can it 
then be due to shorter delays to initiation of 
BLS measures including chest compressions, 
the importance of which has been shown by 
Herlitz and colleagues ?[160]. In the present 
study, however, no relationship appeared 
between survival and of timing start of 
CPR.   
 Despite the short delay to defibrillation, 
in hospital, outcome is worse than in rapid 
defibrillation after OHCA [164]. Obviously 
this may be due to co-morbidities of the 
resuscitated IHCA patients, but one can 
speculate whether the time intervals are 
accurately collected and documented in the 
hospital [41].      
AEDs in the in-hospital setting
A more widespread use of AEDs may be 
a possible way to shorten the delay to 
defibrillation in the hospital [49]. A review 
by Kenward and colleagues identified a 
marked paucity of primary research relating 
to the use of AEDs in the hospital [165]. 
They presented data even suggesting that 
in hospitals with well-established manual 
defibrillator programs, the introduction of 
AEDs may result in decreased survival [165]. 
In some other studies, limited by study size, 
survival rates of patients with their VF/VT 
occurring on the GWs ranged from 26 to 60% 
[165-167]. 
 The present study showed that 40% of 
Finnish hospitals have AEDs, but whether 
these are used in early defibrillation 
programs was not addressed. A large number 
of the Finnish primary and secondary 
hospitals have decided not to purchase 
AEDs. In a Swedish survey less than half 
the hospitals had defibrillators on non-
monitored wards and can be assumed not 
to have rapid defibrillation programs using 
AEDs [Herlitz, personal communication]. 
 Interestingly, in EK-CH, where the 
majority of CA patients were defibrillated 
by a nurse, only manual defibrillators were 
in use. In J-CH and V-CH, the two hospitals 
that had AEDs on the GWs, the apparatus 
was used in only one resuscitation attempt. 
Similar results have been reported from 
a large IHCA registry in the USA. [41]. 
Thus, implementation of an in-hospital 
AED program must be accompanied by 
rigorous training in BLS and in the use of 
the apparatus as a part of it. 
 On GWs, the incidence of initial rhythms 
requiring defibrillation seems to be low (8%) 
as in other studies [15]. In fact, only one 
patient in each hospital with VF/VT as the 
initial rhythm was resuscitated on the GW. 
The study hospitals had eight to twelve GWs, 
and therefore a CA occurring in a patient in 
this setting and requiring defibrillation, 
and thus hypothetically gaining from the 
use of an AED is a rare event. At present, 
the Resuscitation Guidelines emphasize the 
importance of AEDs in the achievement of 
rapid defibrillation in the hospital. But there 
is imminent need for further prospective 
research emphasizing cost effectiveness, 
among other issues. Such studies are being 
undertaken addressing public access to 
defibrillation [168]. An additional strategy 
would be to place the ward AED near those 
patients with, at least a moderate risk for 
CA, i.e., patients transferred from the CCU/
ICU awaiting PCI or similar interventions.   
 Nevertheless the present study showed on 
GWs a substantial number of resuscitation 
attempts in which the initial rhythm was 
undetermined (21%). One can only speculate 
that VF/VT might have been the initial 
rhythm. A clear advantage of the AED is that 
rhythm recognition by staff is unnecessary 
for defibrillation.
 It is thus concluded that the impact of 
AEDs on survival in IHCA management 
must be evaluated further. AEDs are only 
a part of the resuscitation management 
strategy. Again continuous data collection 
is of profound importance. On GWs where 
CA is expected to occur with some frequency, 
AED programs may be useful. They may also 
be applied in wards where delay to arrival 
of the resuscitation team is long, but AED 
programs are probably unnecessary in all 
GWs in Finnish hospitals at the secondary 
level of care.        
 
Resuscitation management
Half the secondary and tertiary hospitals 
managed their CAs with resuscitation 
teams. This may have several advantages. 
Resuscitation is a rare event in non-critical 
areas, so it seems logical have them handled 
by physicians and nurses with practical 
experience in resuscitative interventions 
such as endotracheal intubation. If ROSC is 
achieved, transportation of the patient to the 
ICU can be rapidly and safely accomplished 
by this trained team. Despite use of a team, 
measures taken by the general hospital 
staff on site, especially defibrillation in 
case of VF/VT are probably crucial, in some 
hospitals, as shown in a study by Soar and 
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colleagues in which patients surviving to 
hospital discharge were those who had 
ROSC established before arrival of the team 
[72]. In other hospitals, this may not be the 
case due to shorter delays in arrival [15]. It 
may be concluded that even though the delay 
to arrival is short, the actions taken by the 
staff on-site are of fundamental importance. 
Based on corresponding in-hospital time-
delays, prior decisions should be made, 
whether staff on the ward use BLS without 
defibrillation, or use defibrillation using 
AEDs or even manual defibrillators.         
IN-HOSPITAL UTSTEIN GUIDELINES 
The study showed that approximately half of 
Finnish hospitals performed systematic data 
collection, but few (11%) of them according 
to the Utstein Guidelines. In Rome 6% of the 
hospitals collected data according to Utstein 
Guidelines [169]. In a survey of in-hospital 
resuscitation management in Sweden, half 
the hospitals had registries on in-hospital 
CPR enabling statistical analysis [161]). The 
situation seems to be similar in Finland. 
 Recent studies from Finland and Denmark 
have shown that crucial CA variables such as 
initial rhythm are inadequately documented 
in the medical charts following a resuscitation 
attempt [170-172]. In the present study, 
initial rhythm was documented in 91% of 
the resuscitation attempts compared to 85% 
reported by Skogvoll and co-workers [15].  
 Guidelines include some conflicting 
definitions. They present six alternatives for 
initial rhythm, one being bradycardia. This is 
inconsistent with the definition of CA given 
in the Guidelines, i.e., a lack of circulation 
confirmed by the lack of a palpable pulse! 
[1]. This has previously been pointed out for 
instance by Patrick and colleagues [14]. 
 The in-hospital Utstein Guidelines are 
logical but sometimes considered exhaustive 
[14,15]. For consecutive routine use, a 
slightly compressed model would better 
serve the purpose. Most of the suggested 
data is probably not relevant for developing 
in-hospital resuscitation strategies in 
individual hospitals. The registration of 
the suggested gold-standard time intervals: 
delay to defibrillation if in VF/VT, delay to 
airway management and administration of 
adrenaline in all other patients, appears too 
ambitious. Apparently, emphasis must be on 
obtaining few but exact time intervals. In this 
sense, the interval to arrival of a physician or 
a resuscitation team, to defibrillation and to 
ROSC seems relevant. These are analogous 
to the intervals to BLS, ALS, and ROSC, the 
data most used concerning OHCA [13]. 
    
PATIENTS SUFFERING UNWITNESSED CA 
ON THE WARDS 
Whether or not to start resuscitation in cases 
of unwitnessed CA on the wards is an issue 
that has not been scrutinized. The present 
study found, among resuscitated patients 
suffering unwitnessed CA on the wards, no 
survivors. Whether a larger proportion of 
these patients could have been saved with 
a more effective in-hospital resuscitation 
strategy is a matter of debate. The finding is, 
nonetheless, in accordance with the validated 
clinical decision aid recently developed for 
CA management, emphasizing GWs [88]. 
 In the present study, resuscitation was 
also more likely attempted when the arrest 
occurred during daytime working hours. 
This finding is rather delicate to interpret, 
but may be due to the fact that insufficient 
staff and organization after office hours 
result in longer delays of arrest recognition 
and resuscitation attempts.
DNAR ORDERS AND LIVING WILLS
DNAR policies and prevalence of 
DNAR orders
The study showed that most Finnish 
hospitals (91%) have a DNAR order policy 
and that most patients (85%) that suffered 
CA without resuscitation being initiated 
in those hospitals studied, indeed had a 
DNAR order. Accordingly most patients who 
suffered CA without attempted resuscitation 
in Sahlgrenska Hospital in Gothenburg 
(82%) [173], as well as in Liverpool Hospital 
(90%) in Sydney, Australia (Parr, personal 
communication), had a DNAR order in 
place. Interestingly, most Finnish hospitals 
reported that resuscitative efforts could be 
withheld without a DNAR order in futile 
cases based on a decision of the attending 
physician, or in fewer cases, by the attending 
nurse. 
Factors associated with the presence 
of DNAR orders
Patients of high age and of poor functional 
status were more likely to have a DNAR 
order present, supporting previous findings 
[119,174]. Interestingly there was also a 
difference in prevalence of DNAR orders 
among the four study hospitals, despite 
equivalent DNAR policies. This is in 
accordance with a Swedish study showing 
variation in end-of-life decision-making 
among several centers [175].   
 Female gender was not associated with 
the presence of a DNAR order, contradicting 
previous findings [119]. In the present study 
DNAR orders were more common among 
patients admitted for non-cardiac causes. 
This implies that DNAR orders were issued 
somewhat differently depending on medical 
condition, in some cases even despite similar 
prognoses [176,177].
 There seems to be a difference in the 
prevalence of DNAR orders among different 
in-hospital areas. In this study, most 
patients suffering CA without CPR, at the 
“monitored” units, such as the CCU/ICU 
had DNAR order in place. These patients 
were critically ill, and CA and death may 
have been anticipated. On GWs, on the other 
hand, despite terminal illness, death may 
have been unexpected. As expected, patients, 
not resuscitated, and issued a DNAR order, 
had been in the hospital for a longer time. 
Still, in some cases DNAR-associated issues 
could be addressed as early as possible, even 
soon after admission.
Documentation of DNAR orders
That few Finnish hospitals had a unified 
style of charting the DNAR order may have 
led to inconsistencies. Indeed, the four 
secondary hospitals studied (II-III) lacked a 
uniform style of notation, and DNAR orders 
were charted in two different places. Similar 
problems concerning charting have been 
highlighted [178]. Poor documentation has 
resulted in inadvertently initiated CPR [179]. 
In this study, no patients received CPR if 
they had a DNAR order, but inconsistencies 
occurred among patients in whom CPR was 
not initiated, despite the fact that they did 
not have a DNAR order. The majority of 
these patients had terminal disease, and 
a DNAR order may have been oral. This 
is undesirable, because staff, especially 
the physician, witnessing the arrest may 
not know the patient´s history, and rapid 
decision-making is necessary. Another 
explanation may be that although the patient 
had terminal disease, death was unexpected. 
In some cases, issuing a DNAR order at 
an early stage of a terminal illness may be 
considered “too final”, perhaps reflecting 
lack of clinical experience, or of seniority. In 
any case, keeping in mind that the results 
of in-hospital CPR overall are poor, it would 
be logical to issue a DNAR order for patients 
in whom treatment is being limited due to 
medical futility. A rational attitude towards 
DNAR may require change in the in-hospital 
culture or in traditions, as was shown in the 
300-bed Danderong hospital in Australia, 
where the prevalence of DNAR orders 
increased after the introduction of a MET 
[128]. The emphasis of CA management and 
of DNAR policies is on prevention, rather 
than treatment.
   
Patient autonomy 
The hospitals included in this study had 
adopted a policy to discuss DNAR decisions 
with patients. The Finnish Law on the 
Patient´s Status and Rights that was ratified 
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in the year 1992, states that patients should 
be heard in medical decisions. In contrast to 
the situation in the UK, in Finland, specific 
practical guidelines for DNAR decision-
making are lacking. The UK guidelines 
(1999) state explicitly that DNAR decisions 
should be discussed with the patient [180]. 
In the United States, the Patient Self-
Determination Act (PSDA) states that all 
hospitals need to ask their patients for living 
wills and, in the case of no living will, they 
should offer an opportunity to complete one 
[181]. Following the PSDA, the prevalence of 
living wills rose from 4% in 1990 to 13% in 
1993, and of DNAR decisions from 30 % to 50 
%, respectively, in the nursing homes of 10 
states in the USA [182].
Living wills
 In the present study, few patients had living 
wills, probably a reflection of a difference 
in the culture of medical practice here. All 
patients with a living will had been assigned 
a DNAR order, as well. Thus, it could be 
argued that the living will had an influence 
on patient care. Even so, some studies have 
been unable to show such an influence 
[123,124].   
Limited resuscitation
In the present study, a small portion of 
severely ill patients had an order to limit 
resuscitative interventions to defibrillation of 
a potentially treatable arrhythmia, probably 
because most clinicians acknowledge the 
well-documented increased survival from 
CA among patients resuscitated from VF/VT 
[64]. Use of limited resuscitation attempts 
in Canada was discussed by Chourhy and 
colleagues [183], who conclude that limiting 
resuscitation to defibrillation for VF/VT 
may be justified in cases of witnessed and 
monitored CA. Still, further interventions 
such as airway management and intensive 
care may be required, putting the clinician 
in charge of the resuscitation in a rather 
difficult position.  One must recognize 
that in a study by Dumont and colleagues 
none of those patients subjected to limited 
resuscitation attempts survived [37].   
USE OF UNDILUTED AMIODARONE IN 
OHCA MANAGEMENT
Haemodynamic considerations 
concerning undiluted amiodarone
In this study, undiluted amiodarone caused 
no serious side-effects such as uncontrolled 
hypotension or bradycardia. The fact that 
adrenaline was used concomitantly in 
most patients may have been crucial. In 
VF in pigs, use of amiodarone (5 mg/kg) 
without adrenaline resulted in significantly 
decreased coronary perfusion pressure 
(CPP) one minute after administration 
[184]. If adrenaline (0.02 mg/kg) was given 
simultaneously, CPP did not decrease. 
This finding is of greatest interest because 
sufficient CPP is needed to achieve 
ROSC [185]. A recent study on the use of 
mechanical chest compressions in an animal 
model of CA also underlined the importance 
of optimal haemodynamic conditions 
facilitating defibrillation [186]. That study 
by Steen and colleagues, and novel studies 
on the importance of chest compressions 
before defibrillation in OHCA [187,188] 
may, in fact, lead to caution in using any 
therapy perhaps resulting in a decrease in 
CPP in CA.  CPP was impossible to measure 
in the present study, but blood pressure 
levels after achievement of ROSC were 
comparable to those of patients resuscitated 
without amiodarone.  The post-ROSC blood 
pressure levels of the patients who received 
undiluted amiodarone were comparable 
to levels among patients receiving diluted 
amidoarone in the study by Kudenchuk 
and colleagues [136]. The levels are also in 
accordance with blood pressure and heart 
rate levels reported on admission to the 
hospital in patients resuscitated after of 
out-of-hospital VF in general [92,97,189]. 
The heart-rate levels were lower after 
administration of amiodarone but seldom 
met the criteria of bradycardia, and only a 
few patients required treatment. 
 In resuscitated CA patients, recurrence of 
VF is a major cause of mortality [190], and 
therefore an antiarrhythmic agent may serve 
well. Dorian and colleagues found regarding 
use of amiodarone in OHCA management, 
that in patients with recurrence of VF, 
those given amiodarone were more likely 
to survive to hospital admission than those 
on lidocaine [137]. In the present study, no 
significant hypotension occurred in a small 
subset of six CA patients who received 
amiodarone without adrenaline. But it is 
noteworthy that those patients may have 
had stable haemodynamic also due to short 
delay to initiation of BLS and ALS. 
 The pharmacological treatment protocol 
in OHCA should perhaps be modified 
according to delay. If delay to initiation 
of ALS is short, i.e., not longer than five 
minutes, defibrillation and perhaps an 
antiarrhythmic agent such as amiodarone 
should be administered. A longer delay 
should include chest compression and a drug 
which increases CPP such as adrenaline or 
vasopressin. Use of undiluted amiodarone, 
as the antiarrhythmic agent seems feasible 
in OHCA management, but its effect on long-
term outcome is yet to be determined.
The use of undiluted amiodarone
A concentrated amiodarone solution may 
cause hypotension and infusion phlebitis 
(Cordarone, IV. Prescribing Information). 
Prescription information in Finland has been 
revised quite recently so that an undiluted 
bolus of amiodarone may be administered 
intravenously during CPR, but a rapid 
bolus of crystalloid fluid has to be given 
immediately thereafter. Infusion phlebitis 
is not a serious side-effect in resuscitation. 
Risk is probably negligible if amiodarone 
is administered in a large vein as centrally 
as possible. The hypotension associated 
with rapid intravenous amiodarone 
administration is thought to be caused by the 
solvent, which is why a new water-soluble 
preparation of amiodarone (Amio-Aqueous) 
is under development.
 In this study, amiodarone was 
administered as a bolus, i.e., within a few 
seconds. Hypothetically, if amiodarone had 
been administered in a centrally located 
vein, in undiluted form, but in smaller 
doses during 20 to 30 seconds, the effect 
would probably have been equal to the 
administration of diluted amiodarone. We 
may speculate whether this would have 
changed the incidence of hypotension after 
ROSC.
Outcome of patients with OHCA
Outcome after VF/VT was similar to that 
in previous reports by the Helsinki EMS 
some 10 to 15 years earlier [134,191]. Of 
those patients with asystole or PEA as the 
initial rhythm and VF appearing during 
the resuscitative efforts who then received 
amiodarone, 10% survived until hospital 
admission. Kudenchuk and colleagues 
found survival to hospital admission among 
patients receiving amiodarone with an initial 
rhythm of asystole and PEA to be 17% [136]. 
Survival among resuscitated patients with 
PEA as the initial rhythm is low [192], and 
few develop VF/VT. In the present study, of 
the patients in this category, none survived 
to be discharged. It may be expected that 
when hypovolemia is the cause of PEA, the 
potent vasodilatory effect of amiodarone 
can be harmful, but studying this in a 
randomized and controlled fashion would be 
difficult.
THE IMPACT OF POST-RESUSCITATION 
CARE ON SURVIVAL AFTER OHCA
Overall survival rates and pre-
hospital factors predictive of 
survival
In the present study multiple logistic 
regression analysis was served for predicting 
survival from OHCA. Formerly patient 
characteristics and pre-hospital variables 
were of great importance [193,194], leading 
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to measures to improve the survival rates of 
patients in CA. Perhaps the most ambitious 
of these measures is the use of AEDs by 
others than health care professionals in the 
out-of-hospital setting [168,195,196]
 This study supports earlier findings 
that also certain in-hospital factors predict 
survival from OHCA [93]. Consequently, 
that in-hospital care of survivors of OHCA 
may indeed have an impact on long-term 
outcome is an endorsement of Engdahl and 
colleagues [92]. 
 Of the patients hospitalized alive after 
OHCA, 68% survived to hospital discharge, 
and 57% were alive at 6 months. This is 
in line with reports from Helsinki [134], 
and other centers [92,93,148,197]. In the 
present study, advanced age and interval 
to ROSC were predictive of survival from 
OHCA, in accordance with previous findings 
[148,150,155,198].    
Blood glucose and mortality
Hyperglycaemia was associated with 
mortality at 6 months from the event in the 
multiple logistic regression models including 
several pre-hospital and in-hospital patient 
variables. The lowest rate of mortality (9%) 
was in patients nearly normoglycaemic 
(5.8-6.8 mmol/l). Several reasons may 
explain hyperglycaemia in resuscitated 
patients. On admission, it may be due to the 
administration of adrenaline [199]. During 
further intensive care, hyperglycaemia is 
probably in most part due to the insulin 
resistance commonly seen in critically ill 
patients [200].  
 Maintenance of normoglycaemia has 
recently been beneficial in surgical patients 
requiring intensive care [112]. Van den 
Berghe and colleagues showed that blood 
glucose level per se, not the magnitude 
of insulin treatment was associated with 
increased survival [113].
 Given the deleterious effect of 
hyperglycaemia in various neurological 
insults such as stroke [100,101,201], it would 
seem reasonable to avoid hyperglycaemia 
in patients resuscitated from cardiac 
arrest. The mortality difference among 
patients nearly normoglycaemic (9%) and 
those hyperglycaemic (50%) in the present 
study is astonishing. However, one cannot 
assume that mortality could be lowered 40% 
through any hypothetical maintenance of 
normoglycaemia with insulin. A controlled 
randomised study is warranted to clarify 
this issue. On the other hand, the ethics 
of such a study and accordingly the design 
would need careful appraisal.      
Use of beta-blocking agents and 
survival
Here, the use of beta-blocking agents during 
post-resuscitation care was associated 
with better survival. Administration of 
beta-blocking agents early in myocardial 
infarction has reduced both short´ and long-
term mortality [202-204]. This reduction has 
been associated with reduction in infarct 
size [205,206], and with lesser recurrences 
of life-threatening arrhythmias [207-209]. A 
growing body of evidence thus reveals that 
beta-blocking agents are beneficial in acute 
myocardial ischaemia and infarction, and for 
these cases they are indeed recommended by 
the Resuscitation 2000 Guidelines [2]. 
 Studies have concluded that acute 
coronary occlusion accounts for 36 to 95% 
of OHCAs [210,211]. At the same time 
clear ECG findings indicative of myocardial 
ischaemia such as elevation or depression 
of the ST-segment are present in only about 
half the patients resuscitated from out-
of-hospital VF [92,212]. Normal ECG on 
admission thus does not exclude coronary 
occlusion. Immediate angiography followed 
by intervention when indicated improves 
survival in subsets of CA patients [212]. 
Indeed, some of the current patients 
underwent coronary angiography, and 
PCI when indicated.  The impact of these 
interventions on survival is difficult to 
determine. Earlier, such examinations 
or treatments were seldom performed 
in the first hours of post-resuscitation 
care. Secondly, these patients represent a 
selection with good primary recovery, i.e., 
such procedures are not usually performed on 
those neurologically disabled or comatose.    
 The connection between survival and 
use of beta-blocking agents in the present 
study was independent of ECG findings and 
cardiac enzyme levels on hospital admission. 
Excitingly, patients prescribed beta-blockers 
at discharge from hospital after CA also 
have better long-term survival [92]. All in 
all these findings are intriguing keeping in 
mind the fact that HIE following CA causes 
the morbidity. Obviously, the difference in 
mortality in the present study is unlikely 
to be explainable solely by beta-blocking 
agents. One may speculate whether a larger 
proportion of the patients might have had 
CAs due to cardiac causes. 
  Hypotension is common in the post-
resuscitation period sometimes making 
beta-blocking agents contraindicated. In this 
study, no significant differences appeared 
among blood pressure level and need for 
vasopressor agents among those receiving 
and not receiving beta-blocking agents. 
Amiodarone, the use of which began in 
Finland in October 2000, was not included 
in the regression models, because very few of 
the in-hospital care patients analyzed (1998-
2000) received amiodarone. The combination 
of amiodarone and a beta-blocker has been 
feasible in the treatment of VT, however 
[213]. So, no harm can be expected if patients 
receiving amiodarone before hospitalisation, 
are given beta-blocking agents during post-
resuscitation care.    
Potassium levels and survival
The multiple logistic regression models 
revealed that blood potassium levels during 
post-resuscitation care were associated with 
survival. The trend is towards a higher 
mortality among hyperkalaemic patients 
and a lower mortality among those slightly 
hypokalaemic. Even so, what needs to be 
acknowledged is that most of the blood 
(plasma or serum) potassium levels fell 
within normal limits (3.3-5.1 mmol/l). 
Potassium levels are often elevated directly 
after a CA [214]. Non-survivors have had 
higher potassium levels and lower arterial 
bicarbonate levels on admission to hospital 
than did survivors after OHCA [197]. Base 
excess levels exceeding -3.5 mmol/l have 
been predictive of survival [93]. Increased 
potassium levels have been connected 
with tissue damage resulting in potassium 
release from the cells, and with metabolic 
acidosis [215]. Impaired circulation and 
tissue oxygenation resulting in acidosis 
and a subsequent potassium release, might 
in part explain the association between 
potassium levels and mortality seen here.     
      
Non-significant factors
Several factors were associated with 
mortality according to univariate analysis 
but not to multiple logistic regression 
analysis. This may in part be due to limited 
population size. Even so, it was intriguing 
to find no correlation between survival 
and mean blood pressure levels and use of 
vasopressors during the first 72 hours of 
hospital care. Most patients did, indeed, 
receive vasopressors and therefore no 
hypotension occurred. This might in theory 
explain the absence of any correlation 
between hypotension and survival. The fact 
that most guidelines have emphasized the 
importance of avoiding hypotension during 
post-resuscitation care may explain the 
current practice. Maintaining head elevation 
at 30 degrees, if blood pressure is sufficient, 
can be useful, because it lowers intracerebral 
pressure [216]. In this study, however, this 
was not the routine procedure.      
Quality of post-resuscitation care 
 Variability in management of resuscitated 
patients was noted. Emphasis was on 
avoiding hypotension by frequent use 
of vasopressors. The overall impact of 
aggressive haemodynamic treatment and 
blood pressure monitoring of resuscitated 
patients is unclear [97]. On the other 
hand, blood glucose levels were monitored 
only twice daily, on average, which can 
be regarded as insufficient, given the 
deleterious effects of hyperglycaemia [113].
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SUBJECTIVITY
The cross-sectional mail survey of IHCA 
management in Finnish hospitals is limited 
to a description of the situation in the year 
2000. Moreover, it is based on the subjective 
opinions of only one respondent per hospital 
(I). With no standardized way of determining 
the OPC-category of the survivors, these data 
may in some cases be inaccurate (II-III,V). 
TIME INTERVALS
The difficulties of accurately collecting data 
concerning CPR, especially time intervals, 
must also be acknowledged. Most time-
intervals were measured only to the minute 
and are therefore approximations. There 
was no uniform method for measuring time-
intervals in the study hospitals (II). On the 
other hand, we need more data on the use 
of more exact methods for time-interval 
measurements. 
DNAR ORDERS
The study (III) on the use of DNAR orders 
in four secondary hospitals during one year 
is limited because it includes only 77% of 
all in-hospital deaths. The high prevalence 
of DNAR orders may in part be due to the 
on-going study itself, meaning that the 
in-hospital DNAR practice received more 
attention and subsequently more DNAR 
orders were issued. This is, nevertheless, 
one additional benefit of continuous Utstein 
Style data collection (III). 
– LIMITATIONS OF THE STUDY –
DIFFICULTIES TYPICAL FOR 
RETROSPECTIVE STUDIES 
The study on the use of undiluted 
amioadarone is limited mainly because of 
a lack of any control group (IV). Moreover, 
blood pressure measurements during the 
post-ROSC pre-hospital period were not 
performed in a standardized fashion. This, 
on the other hand, probably represents the 
current clinical manner of monitoring in 
other EMS systems as well. In addition, 
the exact timing of the administration of 
amiodarone is unknown (IV).
 The study on post-resuscitation care 
suffers from the typical shortcomings of 
retrospective studies. The laboratory values, 
in particular, were measured at varying 
frequency, so the number of measurements, 
was included in each multiple logistic 
regression model. The laboratory values 
studied were not measured in a standardized 
fashion, e.g., bedside measurement methods 
used for blood glucose were also included. 
Still, this probably reflects the manner of 
clinical monitoring in general (V). 
THE IMPACT OF CLINICAL 
INTERVENTIONS
It was difficult to determine the possible 
impact of cardiological and surgical 
interventions such as PCI and CABG on 
survival after OHCA. These interventions 
were not routinely performed during the first 
days of post-resuscitation care and they are, 
in general, performed on a selected patient 
material, i.e., those who have achieved a 
favourable neurological recovery (V).
– SUMMARY AND CONCLUSIONS –
The present study addressed different 
aspects of current CA management and post-
resuscitation care in and outside the hospital 
in Finland, with reference to Utstein and the 
Resuscitation 2000 Guidelines. The specific 
conclusions are:   
1. Given the recommendations of the 
Resuscitation 2000 Guidelines, the present 
study suggests that more attention has 
to be focused on the current in-hospital 
resuscitation strategies. Not all hospitals 
have one person in charge of resuscitation 
training and equipment, and few hospitals 
have early defibrillation programs in 
non-monitored, and only half of them in 
monitored wards. Nurses were better off 
than physicians regarding CPR training, 
independent of hospital level. A majority 
of respondents reported that the CPR 
training in their hospitals was insufficient. 
A significant proportion of these hospitals 
performed systematic resuscitation data 
collection, but few with reference to the 
Utstein Guidelines.
2. The in-hospital Utstein Guidelines 
were logical and clear to fill in but seemed 
too ambitious for practical use. Some 
clarifications and abridgements might make 
the model more suitable for routine use. Most 
Utstein variables were collected successfully, 
but emphasis should be placed on recording 
the interval to ROSC in all resuscitated 
patients. The survival to hospital discharge 
in four Finnish secondary hospitals was in 
line with prior reports´ (17%), but the long-
term survival rate was somewhat lower (9%). 
Neurological recovery at discharge was also 
somewhat worse than in previous studies. 
The survival rates of patients resuscitated in 
GWs was low. The only factor associated with 
survival was delay to defibrillation. The low 
survival may be due to issues not amenable 
to organizational interventions, but it seems 
logical to strive for a shortened delay to 
defibrillation. This is probably accomplished 
not only with implementation of AEDs but 
also with strenuous organizational efforts. 
Most patients who suffered CA without CPR 
had a DNAR order in place prior to death. 
Terminal illness was often the situation 
among those who died without a DNAR 
order. Inconsistencies, however, existed 
in the documentation of the DNAR order, 
probably due to the lack of guidelines on use 
and documentation of DNAR orders. 
3. The present study suggests that 
in OHCA management, the use of 
undiluted amiodarone, when administered 
concomitantly with adrenaline, is not 
associated with unmanageable side-effects. 
Blood pressure levels of patients after ROSC 
were similar among those who did and did 
not receive amiodarone. Use of undiluted 
amiodarone is likely to save time and does 
simplify the current OHCA treatment 
protocol. 
In addition to patient characteristics and 
pre-hospital variables, several in-hospital 
variables independently predicted survival 
at 6 months after OHCA. This study 
therefore supports previous findings that 
in-hospital care may indeed be of greater 
importance than formerly assumed. In 
addition to age and delay to ROSC, mean 
blood glucose and potassium in the first 72 
hours and use of beta-blocking agents during 
post-resuscitation care predicted survival at 
6 months. Further studies are warranted to 
determine whether these factors are open to 
any clinically beneficial interventions. 
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COST-EFFECTIVENESS OF CURRENT 
RESUSCITATION STRATEGIES
Long-term survival after IHCA is poor. 
In this study, for one survivor one year 
from the arrest the number (of patients) 
needed to treat (resuscitate) was eleven. 
The cost-effectiveness of current in-hospital 
resuscitation systems is low in comparison 
with interventions such as CABG and the 
placement of an implantable defibrillator 
[217]. Further critical assessment of IHCA 
and OHCA management is therefore 
warranted, to enable rational allocation 
of resources and facilitate quality 
improvement. 
 The following approaches, addressing key 
factors of ICHA and OHCA management, 
may be outlined: 
PREVENTION
Evidence exists that most in-hospital CA 
patients, especially those with asystole or 
PEA as the initial rhythm, have clinical 
signs of deterioration before the arrest. 
These patients do not gain much from 
aggressive ALS measures by a resuscitation 
team after the arrest has occurred. Instead, 
these patients should be identified in time, 
possibly permitting clinically beneficial 
interventions. This will also mean that 
patient assessment, especially of those 
seriously ill patients who are treated on 
the GWs, needs improvement [218]. More 
resources or a more efficient utilization 
of existing resources, both in terms of 
monitoring and education, are necessary.
RESUSCITATION MANAGEMENT
Patients whose CA is sudden or unexpected 
are likely to have an arrest of cardiac origin, 
and subsequently VF/VT as the initial 
– FUTURE IMPLICATIONS –
rhythm. These patients are the ones with 
much to gain from an efficient in-hospital 
resuscitation response. CA is, in most GWs, a 
rare event, further highlighting the need for 
regular training of hospital staff in CPR. The 
assignment of a service devoted to education 
and management of CPR-related activities 
in all hospitals in Finland is recommended.    
 In some cases of CAs in the GWs, 
management will include first-responder 
defibrillation by ward nurses using AEDs. 
There is, nevertheless, a need for high-quality 
research into cost-effective implementation 
of AEDs in IHCA management. At present, 
rapid defibrillation is perhaps even more 
urgent in the CCU/ICU setting than 
elsewhere. 
  
MEDICAL FUTILITY
In cases of medical futility, treatment should 
be limited. Patients considered not to be 
benefiting from intensive care or similar 
radical interventions seldom benefit from 
resuscitation after CA. Recording a DNAR 
order in a patient´s medical chart can be 
considered mandatory. A national consensus 
would help to clarify this practice.
POST-RESUSCITATION AND SECONDARY 
PREVENTION STRATEGIES
A need exists for standardisation of 
immediate post-resuscitation care strategies 
and for the secondary prevention of 
OHCA and IHCA cases. Mild therapeutic 
hypothermia, the only intervention 
conclusively shown to improve survival and 
neurologic recovery after OHCA, should be 
made available throughout Finland. Some 
other aspects of post-resuscitation care, such 
as avoidance of hyperglycaemia, needs to be 
evaluated further in a randomised fashion. 
Additional benefit could probably come 
through emphasis on secondary prevention 
such as cardiological intervention and 
follow-up of resuscitated CA patients.
DOCUMENTATION AND AUDIT
Registering and reporting the results of 
resuscitation activities on a national level 
should be encouraged. Thus far, international 
experience with National Registries of CPR 
is promising [41]. Domestic guidelines on 
IHCA management, including condensed 
recommendations for data collection based 
on the current international Guidelines 
[1], would provide insight into current 
status on a national basis. This would also 
enable participants to critically audit CA 
management effectiveness among hospitals. 
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Genom introducerandet av basal och 
avancerad hjärt-lungräddning (HLR, A-
HLR) på, och senare även och utanför 
sjukhus, under 1960-talet har överlevnaden 
för patienter med hjärtstillestånd för-
bättrats. Förbättringen har varit speciellt 
markant bland de patienter som drabbas 
av en livshotande rytmstörning såsom 
kammar flimmer eller kammartakykardi 
till följd av akut hjärtinfarkt. Ett extensivt 
internationellt forskningsarbete under 
senare år har resulterat i att de första 
enhetliga internationella riktlinjerna för 
HLR samt för rapporterandet av HLR 
resultat, publicerades år 2000 respektive år 
1997. Denna doktorsavhandling, som består 
av fem tidigare publicerade delarbeten, 
behandlar olika aspekter, såsom beredskap, 
skolning, organisation, och resultat av HLR 
på och utanför sjukhuset i Finland baserat 
på dessa internationella rekommendationer. 
HLR organisationen på finländska sjuk-
hus studerades med hjälp av en enkät som 
adresserades till alla krets-, central- och 
universitetssjukhus i Finland år 2000. 
Studien påvisade att 75% av sjukhusen har 
en läkare eller en sjukskötare ansvarig för 
HLR verksamheten på respektive sjukhus. 
Skolning i HLR förekommer, men är inte 
alltid regelbunden eller strukturerad. På 
50% av de finländska sjukhusens  hjärt- 
och intensivvårdsavdelningar utförs de-
fibrillering vid hjärtstillestånd även av 
sjukskötare. På 15% av sjukhusen utförs 
defibrillering vid hjärtstillestånd av sjuk-
skötare även på bäddavdelningar. De flesta 
sjukhus hade en “ej-HLR” praxis men få hade 
klara riktlinjer gällande dokumentation.
Fyra finländska centralsjukhus med-
verkade i en studie gällande HLR resultat 
samt beslut att inte påbörja HLR på 
patienter med hjärtstillestånd under en ett 
– SAMMANDRAG (SWEDISH SUMMARY) –
års period. Studien genomfördes i enlighet 
med de 1997 publicerade Utstein riktlinjerna 
för rapportering av HLR resultat.
Studien påvisade att resultaten av HLR 
på de fyra sjukhusen kan genomföras 
med motsvarande internationella resultat 
(17% skrevs levande från sjukhus). Lång-
tidsprognosen var dock något sämre än i 
tidigare rapporter (9% var vid liv ett år efter 
hjärtstilleståndet). Den enda faktorn som 
inverkade på överlevnaden var intervallet 
mellan hjärtstillestånd och defibrillering 
hos patienter med kammarflimmer eller 
kammartakykardi som första registrerade 
rytm. Studien påvisade även att de flesta 
patienter som dör utan påbörjad HLR 
har tilldelats ett “ej-HLR” beslut innan 
hjärtstilleståndet, men dokumentationen av 
detta beslut var inte enhetlig. En variation 
i frekvensen av “ej-HLR” beslut bland 
patienter med hjärtstillestånd mellan och 
inom sjukhusen kunde även påvisas. 
De nya internationella riktlinjerna för 
HLR rekommenderar att patienter med 
återkommande eller behandlingsresistent 
kammarflimmer skall behandlas med pre-
paratet amiodaron, ett läkemedel som tidigare 
endast använts på sjukhus. Amiodaron är 
dock inte ett optimalt läkemedel för bruk 
vid hjärtstillestånd, pga hemodynamiska 
biverkningar samt av komplicerad dosering. 
I denna studie studerades bruket av 
amiodaron retrospektivt vid hjärtstillestånd 
utanför sjukhus i Helsingfors under 
två år. Studien påvisade inga kliniskt 
märkbara biverkningar bland de patienter 
som docerades amiodaron intravenöst i 
koncenterarad form, utan utspädning som 
gängse rekommendationer förutsätter. 
Detta kan innebära en förenkling av 
HLR protokollet vid hjärtstillestånd. 
Överlevnaden bland patienter med annan 
primär rytm än kammarflimmer eller 
kammartakykardi som doserats amiodaron 
var låg. 
 I det femte delarbetet studerades 
med hjälp av flervariabelanalys den 
omedelbara intensivvårdens självständiga 
betydelse för överlevnad sex månader 
efter hjärtstillestånd utanför sjukhus. De 
patienter som under en period av tre år 
vårdades på ett av tre sjukhus i Helsingfors 
efter ett hjärtstillestånd inkluderades. 
Studien påvisade att även faktorer gällande 
den omedelbara intensivvården på sjukhus 
efter ett hjärtstillestånd har prognostisk 
betydelse. Detta är i enlighet med tidigare 
studier som betonar den omedelbara efter-
vårdens betydelse efter hjärtstille stånd. 
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Peruselvytys, sisältäen suustasuuhun-
puhaltamisen ja rintakehän painelun, on 
ollut osa lääketieteellistä hoitokäytäntöä 
1960-luvulta lähtien. Myöhemmin perus-
elvytykseen liitettiin myös sydämen defibril-
laatio ja elvytyslääkkeet, jonka jälkeen 
kokonaisuudesta käytettiin nimitystä 
hoi to elvytys. Toimiva elvytysjärjestelmä 
sairaalassa sekä sairaalan ulkopuolella luo 
mahdollisuuden sydänpysähdyspotilaan 
sel vi ä miselle. Vuonna 1997 julkaistiin 
ensimmäinen kansainvälinen sairaala-
elvy tystulosten raportointimalli ja vuon-
na 2000 ensimmäiset kansainväliset 
elvy tysuositukset. Tämän viidestä jo 
jul kaisusta osatutkimuksesta koostuvan 
väitöskirjatutkimuksen tarkoitus oli sel-
vittää sydänpysähdyksen hoitoon ja jat-
kohoitoon liittyvien tekijöiden vaikutuksia 
selviämiseen sairaalassa ja sairaalan 
ul kopuolella Suomessa, perustuen edellä 
mainittuihin kansainvälisiin suosituksiin.
Suomen sairaaloiden elvytys käytäntöjä 
selvitettiin vuonna 2000 kaikille Suomen 
alue-, keskus- ja yliopistosairaaloille osoi-
tetulla kyselylomakkeella. Tutkimus osoitti 
että 75%:lla sairaaloista oli tehtävään 
ni metty elvytystoiminnan vastuuhenkilö. 
Elvytyskoulutusta järjestettiin mutta se oli 
harvoin säännöllistä. Noin 50% sairaaloista 
pyrittiin varhaiseen defibrillaatioon te-
ho- ja sydänvalvontaosastoilla, ja 15%:
ssa sairaaloista, myös muilla osastoilla. 
Valtaosalla sairaaloista oli ns ”älä elvytä” 
käytäntö mutta vain muutamalla sairaalalla 
oli sovittu kirjaamistapa. 
Kansainvälisen tilastointimallin käyttö-
kelpoisuutta elvytystulosten raportoinnissa 
ja ei elvytettyjen potilaiden tarkastelussa 
selvitettiin neljässä suomalaisessa kes-
kussairaalassa yhden vuoden ajan. Rapor-
tointimalli todettiin selkeäksi mutta var-
sin työlääksi. Elvytyksestä kotiutuvien 
potilaiden osuus oli verrattavissa aikai-
sempiin tutkimuksiin (17%) mutta vuoden 
kuluttua elossa olleiden osuus oli pienempi 
(9%) kuin aikaisemmissa tutkimuksissa. 
Ainoa tekijä, jonka todettiin vaikuttavan 
suotuisasti ennusteeseen oli lyhyt viive 
defibrillaatioon. Valtaosalle sairaaloissa 
kuol leista ei elvytetyistä potilaista oli tehty 
”älä elvytä” päätös mutta kirjaamistavoissa 
oli eroja niin sairaalan sisällä kuin 
sairaaloiden välillä.
Uudet kansainväliset elvytysohjeet suo-
sittelevat ei-defibrilloituvan kammioväri-
nän hoidoksi amiodaronia. Amiodaroni 
ei kuitenkaan sivuvaikutuksensa ja anto-
tapansa takia ole optimaalinen lää ke 
käytettäväksi elvytyksessä. Tässä tut ki-
muksessa amiodaronia annettiin suonen 
sisäisesti ilman suositeltua laimennosta 
sairaalan ulkopuolella tapahtuneiden sydän-
pysähdysten hoidossa. Tulosten mukaan 
laimentamantonta amiodaronia saaneilla 
potilailla ei todettu vakavia sivuvaikutuksia. 
Kammiovärinästä elvytettyjen potilaiden 
osuus oli verrattavissa aikaisempiin tut-
kimuksiin. Niistä potilaista, joilla alkurytmi 
oli asystole tai sydämen sykkeetön toiminta, 
ja jotka elvytyksen aikana saivat ei-
defibrilloituvan kammiovärinän hoidoksi 
amiodaronia, kukaan ei kotiutunut sai-
raalasta. 
Väitöskirjan viimeisessä osatyössä sel-
vitettiin monimuuttuja-analyysin avulla 
sy dän pysähdyksen jälkeisen tehohoidon 
vai kutusta ennusteeseen. Aineisto koostui 
kolmen vuoden aikana Helsingissä sairaalan 
ulkopuolella elvytettyjen potilaiden jatko-
hoitotiedoista. Tutkimuksessa todettiin että 
potilas- ja elvytysmuuttujien lisäksi, myös 
välitöntä sairaalassa tapahtuvaa tehohoitoa 
kuvaavat muuttujat ennustivat itsenäisesti 
selviämistä kuusi kuukautta tapahtuman 
jälkeen. Tämä tulos tukee viimeaikaisia 
tutkimuksia, joiden mukaan välittömän 
tehohoidon vaikutukset saattavat olla 
suurempia kuin mitä on tähän saakka 
arveltu.
This study was carried out at the Department 
of Anaesthesiology and Intensive Care 
Medicine, University of Helsinki from 1999 
to 2004. 
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Page 278, section 3. Results, line 1 “1690” sould be “1691”
Page 279, section 3.5.4 Time intervals, line 8 “(mean 1 min, median 1 min, range 0-2, S.D. 
1.5) should be “(mean 1 min, median 0 min, range 0-6)”
Page 279, section 3.5.4 Time intervals, lines 9-10 “(mean 5.4 min, median 5 min, range 0-
25, S.D.7)” should be “(mean 5 min, median 1 min, range 0-25)”
Page 279, section 3.5.4 Time intervals, line 12, “21” should be “15”
III
Page 68, section 3.2 DNAR orders, line 1 “966” should be “967”
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